研究実績

研究実績（2015年度-2023年度）を紹介します。

• 論文
• 著書
• 学会発表

• 2023年度

  2022年度

  2021年度

  2020年度

  2019年度

  2018年度

  2017年度

  2016年度

  2015年度
  
  
  

  2023年度

  Jin Y, Wang L, Jin C, Zhang N, Shimizu S, Xiao W, Guo C, Liu X, Si H. A Novel Inhibitor of Poly(ADP-Ribose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA Damage–Activated cGAS–STING Pathway. Chemical Research in Toxicology, 37(4), 561-570, 2024.

  Nakamura M, Mizumoto M, Saito T, Shimizu S, Li Y, Oshiro Y, Inaba M, Hosaka S, Fukushima H, Suzuki R, Iizumi T, Nakai K, Maruo K, Sakurai H. A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024. Frontiers in oncology, 14, 1380716, 2024.

  Yanagihara KT, Tepper EJ, Moon M A, Barry A, Molla M, Seong J, Torres F, Apisarnthanarax S, Buckstein M, Cardenes H, Chang TD, Feng M, Guha C, Hallemeier LC, Hawkins MA, Hoyer M, Iwata H, Jabbour KS, Kachnic L, Kharofa J, Kim HT, Kirichenko A, Koay JE, Makishima H, Mases J, Meyer JJ, Munoz-Schuffenegger P, Owen D, Park CH, Saez J, Sanford NN, Scorsetti M, Smith LG, Wo YJ, Yoon MS, Lawrence ST, Reig M, Dawson AL. Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Practical Radiation Oncology, 14(2), 134-145, 2024.

  Hinoto R, Tsukamoto N, Eriguchi T, Kumada H, Sakae T. Robust and optimal dose distribution for brain metastases with robotic radiosurgery system: Recipe for an inflection point. Biomedical Physics & Engineering Express, 10(2), 2024.

  Niitsu H, Fukumitsu N, Tanaka K, Mizumoto M, Nakai K, Matsuda M, Ishikawa E, Hatano K, Hashimoto T, Kamizawa S, Sakurai H. Methyl‑11C‑L‑methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma. Annals of Nuclear Medicine 38(4), 305-314, 2024.

  Nitta H, Mizumoto M, Li Y, Oshiro Y, Fukushima H, Suzuki R, Hosaka S, Saito T, Numajiri H, Kawano C, Kamizawa S, Maruo K, Sakurai H. An analysis of muscle growth after proton beam therapy for pediatric cancer. Journal of Radiation Research, rrad105, pp.1-5, 2024.

  Takizawa D, Okumura T, Mizumoto M, Nakai K, Sakurai H. A case of circumscribed choroidal hemangioma treated with proton beam therapy and followed up for 15 years. Cureus, 16(1), e52389, 2024.

  Niitsu H, Mizumoto M, Li Y, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Makishima H, Nakai K, Oshiro Y, Maruo K, Sakurai H. Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma. Cancers, 16(2), 357, 2024.

  Takahashi M, Mizumoto M, Oshiro Y, Kino H, Akutsu H, Nakai K, Sumiya T, Ishikawa E, Maruo K, Sakurai H. Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma. Cancers, 15(23), 5687, 2023.

  Nakamura M, Ohnishi K, Nakazawa K, Shimizu K, Miyauchi D, Mizumoto M, Nakai K, Okumura T, Sakurai H. Long-term follow-up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high-dose proton beam therapy: A report of two cases. Thoracic Cancer, 15(2), 201-205, 2023.

  Saito T, Murakami M, Sumiya T, Kobayashi D, Shirataki H, Fujioka D, Baba K, Itagaki H, Tenjimbayashi Y, Satoh T, Sakurai H. Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report. Technical Innovations & Patient Support in Radiation Oncology, 28, 100222, 2023.

  Jin Y, Shimizu S, Li Y, Yao Y, Liu X, Si H, Sakurai H, Xiao W. Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes. Radiation Oncology, 18, 189, 2023.

  Takizawa D, Ishida T, Nakano H, Tachi H, Yamamoto Y, Shimizu K, Iizumi T, Sumiya T, Ohnishi K, Sakurai H. A case of massive hemoptysis caused by lung cancer saved by V‑V ECMO and hemostasis achieved by radiotherapy. International Cancer Conference Journal, 2023.

  森祐太郎, 磯辺智範, 櫻井英幸, 榮武二. クロスリアリティと空中ハプティクス技術を用いた体感型小児陽子線治療支援システムの開発. BIO Clinica, 38(14), 44-47, 2023.

  Yamazaki Y, Terunuma T, Kato T, Komori S, Sakae T. A novel, end-to-end framework for avoiding collisions between the patient's body and gantry in proton therapy. Medical Physics, 50(11), 6684-6692, 2023.

  Kumada H, Sakae T, Sakurai H. Current development status of accelerator-based neutron source for boron neutron capture therapy. EPJ Techniques and Instrumentation, 10, 2023.

  Hiroshima Y, Kondo M, Sawada T, Hoshi S, Okubo R, Iizumi T, Numajiri H, Okumura T, Sakurai H. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. Cancer Medicine, 12(20), 20450-20458, 2023.

  Mizumoto M, Ogino H, Okumura T, Terashima K, Murakami M, Ogino T, Tamamura H, Akimoto T, Waki T, Katoh N, Araya M, Onoe T, Takagi M, Iwata H, Numajiri H, Okimoto T, Uchinami Y, Maruo K, Shibuya K, Sakurai H. Proton beam therapy for hepatocellular carcinoma: Multicenter prospective registry study in Japan. International Journal of Radiation Oncology, Biology, Physics, S0360-3016(23), 07969-07965, 2023.

  Yamaguchi H, Fukumitsu N, Numajiri H, Ogino H, Katoh N, Okimoto T, Suzuki M, Sakurai H. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients. Journal of Radiation Research, 64(6), 926-932, 2023.

  Oshiro Y, Mizumoto M, Miyamoto T, Sumiya T, Fujioka D, Shirataki H, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Makishima H, Nakai K, Maruo K, Sakae T, Sakurai H. Retrospective Analysis of the Areas Responsible for Light Flash and Odor During Proton Beam Therapy and Photon Therapy. Cureus, 15(9), e44790, 2023.

  Hirotaki K, Tomizawa K, Moriya S, Oyoshi H, Raturi V, Ito M, Sakae T. Fully automated volumetric modulated arc therapy planning for locally advanced rectal cancer: feasibility and efficiency. Radiation oncology, 18(1), 147, 2023.

  Iizumi T, Okumura T, Hasegawa N, Ishige K, Fukuda K, Seo E, Makishima H, Niitsu H, Takahashi M, Sekino Y, Takahashi H, Takizawa D, Oshiro Y, Baba K, Murakami M, Saito T, Numajiri H, Mizumoto M, Nakai K, Sakurai H. Proton beam therapy for hepatocellular carcinoma with bile duct invasion. BMC Gastroenterology, 23, 267, 2023.

  Mizumoto M, Terashima K, Makishima H, Suzuki M, Ogino T, Waki T, Iwata H, Tamamura H, Uchinami Y, Akimoto T, Okimoto T, Iizumi T, Murakami M, Katoh N, Maruo K, Shibuya K, Sakurai H. Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan. Liver Cancer, 2023.

  Saito T, Mizumoto M, Oshiro Y, Miyamoto T, Kamizawa S, Nakamura M, Ishida T, Makishima H, Numajiri H, Nakai K, Sakae T, Sakurai H. Synchronization of light flash with the irradiation pulse in proton beam therapy: A case report. Technical Innovations & Patient Support in Radiation Oncology, 27, 100218, 2023.

  Shimomura O, Endo M, Makishima H, Yamada T, Hashimoto S, Numajiri H, Miyazaki Y, Doi M, Furuya K, Takahashi K, Moriwaki T, Hasegawa N, Yamamoto Y, Niisato Y, Kobayashi M, Mizumoto M, Nakai K, Saito T, Hoshiai S, Saida T, Mathis BJ, Mori K, Nakajima T, Tsuchiya K, Sakurai H, Oda T. Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial). BMC Cancer, 23, 624, 2023.

  石川仁, 小此木範之, 青木秀梨, 森祐太郎, 櫻井英幸. Ⅳ.治療　放射線治療　粒子線治療　陽子線治療. 臨床前立腺癌学　ー基礎・臨床の最新知見ー, 81巻　増刊号6, 306-313, 2023.

  Saito T, Nakayama M, Ohnishi K, Tanaka S, Nakamura M, Murakami M, Matsumoto S, Baba K, Fujii K, Mizumoto M, Tabuchi K, Sakurai H. Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus. Radiation Oncology, 18, 106, 2023.

  Nishimura K, Kashiwagi H, Morita T, Fukuo Y, Okada S, Miura K, Matsumoto Y, Sugawara Y, Enomoto T, Suzuki M, Nakai K, Kawabata S, Nakamura H. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP). Journal of Controlled Release, 360, 249-259, 2023.

  Sakae T, Takada K, Kamizawa S, Terunuma T, Ando K. Formulation of Time-Dependent Cell Survival with Saturable Repairability of Radiation Damage. Radiat Res, 200(2), 2023.

  Sakurai H, Ohno T, Ogawa K. Current status and future prospects of particle therapy (proton beam and heavy ion therapy) in Japan—in the special issue of the Journal of Radiation Research. Journal of Radiation Research, 64, i1, 2023.

  Fukushima H, Suzuki R, Yamaki Y, Hosaka S, Inaba M, Masumoto K, Muroi A, Tsurubuchi T, Okubo R, Hidaka K, Mizumoto M, Sakurai H, Takada H. Longitudinal health-related quality of life analysis in childhood cancer survivors after proton beam therapy. International Journal of Clinical Oncology, 28, 928-939, 2023.

  Hiroshima Y, Wakatsuki M, Kaneko T, Makishima H, Okada N, Yasuda S, Ishikawa H, Tsuji H. Clinical impact of carbon-ion radiotherapy on hepatocellular carcinoma with Child-Pugh B cirrhosis. Cancer Medicine, 12(13), 14004-14014, 2023.

  Fukushima H, Mizumoto M, Suzuki R, Yamaki Y, Hosaka S, Inaba M, Tagawa M, Watanabe A, Okunushi T, Masumoto K, Muroi A, Sakurai H, Takada H. Correction to: Gastrointestinal bleeding/ulcer among pediatric cancer patients after proton beam therapy. Japanese Journal of Clinical Oncology, 53(6), 539, 2023.

  Yamazaki H, Shibuya K, Kimoto T, Suzuki M, Murakami M, Terashima K, Okimoto T, Iizumi T, Sakurai H, Wakatsuki M, Suzuki O, Katoh N, Arimura T, Ogino T, Takagi M, Araya M, Waki T, Matsumoto S, Ogino H, Fukumoto T, Ohtsuka M. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net. Clinical and Translational Radiation Oncology, 41, 100634, 2023.

  Mizumoto M, Fukushima H, Miyamoto T, Oshiro Y, Sumiya T, Iizumi T, Saito T, Makishima H, Numajiri H, Hosaka S, Nagatomo K, Yamaki Y, Nakai K, Sakurai H. Analysis of person-hours required for proton beam therapy for pediatric tumors. Journal of Radiation Research, 64(3), 599-601, 2023.

  Kamima T, Iino M, Sakai R, Ito Y, Sakae T, Moriya S, Tokumasu K, Yoshioka Y. Evaluation of the four-dimensional motion of lung tumors during end-exhalation breath-hold conditions using volumetric cine computed tomography images. Radiotherapy and Oncology, 182, 109573, 2023.

  Hiroshima Y, Ishikawa H, Sumiya T, Murakami M, Nakamura M, Ishida T, Ogawa K, Hisakura K, Mizumoto M, Oda T, Okumura T, Sakurai H. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer. In Vivo, 37(3), 1253-1259, 2023.

  Nakamura M, Ishikawa H, Ohnishi K, Baba K, Sumiya T, Murakami M, Hiroshima Y, Mizumoto M, Okumura T, Sakurai H. Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer. ANTICANCER RESEARCH, 43(5), 2003-2013, 2023.

  Araya M, Ishikawa H, Nishioka K, Maruo K, Asakura H, Iizumi T, Takagi M, Murakami M, Azuma H, Obara W, Aoyama H, Sakurai H. Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database. Journal of Radiation Research, 64(Supplement_1), i49–i58, 2023.

  Ishikawa H, Arimura T, Maruo K, Kawamura H, Toyama S, Ogino T, Okimoto T, Murakami M, Sato Y, Nishioka K, Araya M, Ohba H, Umehara K, Aoyama H, Obara W, Azuma H, Tsuji H, Sakurai H. A Japanese registry study and systematic review of particle therapy for renal cell carcinoma. Journal of Radiation Research, 64(_1), i41–i48, 2023.

  Doi Y, Nagata Y, Matsumoto Y, Numata K, Sasaki R, Yamada T, Igaki H, Imagumbai T, Katoh N, Yoshitake T, Shimizuguchi T, Fujioka D, Inoue M, Koide Y, Kimura T, Ito Y. Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma. Hepatology research, 53(8), 749-760, 2023.

  Yamazaki H, Kimoto T, Teramukai S, Fujikawa K, Shibuya K, Suzuki M, Terashima K, Iizumi T, Wakatsuki M, Suzuki O, Fukumoto T, Ohtsuka M. Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer-systemic review and meta-analysis. Journal of Radiation Research, 64(Supplement_1), i34–i40, 2023.

  Hirotaki K, Tomizawa K, Moriya S, Ito M, Sakae T. Impact of Anatomical Position Errors on Dose Distribution in Head and Neck Radiotherapy and Robust Image Registration Against Anatomical Changes. Anticancer Research, 43(4), 1827-1834,

  
  
  

  ▼2022年度

  Li Y, Matsumoto Y, Chen L, Sugawara Y, Oe E, Fujisawa N, Ebara M, Sakurai H. Smart Nanofiber Mesh with Locally Sustained Drug Release Enabled Synergistic Combination Therapy for Glioblastoma. nanomaterials, 2023 ; 13(3), 414.

  Nakamura M, Ishikawa H, Ohnishi K, Mori Y, Baba K, Nakazawa K, Shiozawa T, Sekine I, Maruo K, Okumura T, Sakurai H. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer. J Radiat Res, 2023 ; online ahead of print.

  Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AI, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Kunitake N, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer. J Gynecol Oncol, 2023 ; online ahead of print.

  磯辺智範, 武居秀行, 森祐太郎, 井出仁勇, 小林大輔, 富田哲也, 菅谷奎人, 永井良明, 榮武二. 誌上講座「被ばく」　低線量・低線量率放射線の生物学的影響. 日本放射線技術学会雑誌, 2022 ; 78(11), 1376-1380.

  Saito T, Mizumoto M, Liang HK, Nakai K, Sumiya T, Iizumi T, Kohzuki H, Numajiri H, Makishima H, Tsurubuchi T, Matsuda M, Ishikawa E, Sakurai H. Factors Involved in Preoperative Edema in High-Grade Gliomas. Cureus, 2022 ; 14(11), e31379.

  Terunuma T, Sakae T, Hu Y, Takei H, Moriya S, Okumura T, Sakurai H. Explainability and controllability of patient-specific deep learning with attention-based augmentation for markerless image-guided radiotherapy. Med Phys, 2023 ; 50(1), 480-494.

  Yamazaki K, Nishii R, Mizutani Y, Makishima H, Kaneko T, Isobe Y, Terada T, Tamura K, Imabayashi E, Tani T, Kobayashi M, Wakatsuki M, Tsuji H, Higashi T. Estimation of Post-therapeutic Liver Reserve Capacity Using 99mTc-GSA Scintigraphy Prior to Carbon-ion Radiotherapy for Liver Tumors. Research Square, 2022 ; 50, 581-592.

  Kondo N, Masutani M, Imamichi S, Matsumoto Y, Nakai K. Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System. Cancer Biother Radiopharm, 2022 ; online ahead of print.

  Mizumoto M, Oshiro Y, Miyamoto T, Sumiya T, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Sakae T, Maruo K, Sakurai H. Abnormal sensation during total body irradiation: a prospective observational study. J Radiat Res, 2022 ; 63(5), 792-795.

  Hiroshima Y, Ishikawa H, Iwai Y, Wakatsuki M, Utsumi T, Suzuki H, Akakura K, Harada M, Sakurai H, Ichikawa T, Tsuji H. Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer. cancers(Basel), 2022 ; 14(16).

  Hirotaki K, Moriya S, Akita T, Yokoyama K, Sakae T. Image preprocessing to improve the accuracy and robustness of mutual-information-based automatic image registration in proton therapy. Phys Med,2022 ; 101, 95-103.

  Fujita N, Kanogawa N, Makishima H, Ogasawara S, Maruta S, Iino Y, Shiko Y, Kanzaki H, Koroki K, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Nakamoto S, Chiba T, Wakatsuki M, Itobayashi E, Obu M, Koma Y, Azemoto R, Kawasaki Y, Kato J, Tsuji H, Kato N. Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma. Hepatol Res, 2022 ; online ahead of print.

  Mizumoto M, Oshiro Y, Miyamoto T, Sumiya T, Baba K, Murakami M, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Maruo K, Sakae T, Sakurai H. Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study. Front Oncol,2022 ; 12, 863260.

  Tsurubuchi T, Hara K, Takano S, Muroi A, Fukushima H, Mizumoto M, Sakamoto N, Matsuda M, Akutsu H, Sakurai H, Ishikawa E. Factors Influencing Craniospinal Relapse of Intracranial Germinoma After Complete Remission. World neurosurgery,2022 ; 166, e325-e336.

  Yokoyama K, Kurosaki H, Oyoshi H, Miura K, Utsumi N. Plan Quality Comparison Between Hippocampus-Sparing Whole-Brain Radiotherapy Treated With Halcyon and Tomotherapy Intensity-Modulated Radiotherapy. Technology in Cancer Research & Treatment, 2022 ;21, 1-6.

  Li Y, Shimizu S, Mizumoto M, Iizumi T, Numajiri H, Makishima H, Li G, Sakurai H. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation. Cureus, 2022 ; 14(6), 25744.

  Nakamura M, Ishikawa H, Ohnishi K, Baba K, Saito T, Sumiya T, Murakami M, Hiroshima Y, Nakai K, Mizumoto M, Okumura T, Sakurai H. Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer. Anticancer Res, 2022 ; 42(6), 2953-2960.

  Hiroshima Y, Tamaki Y, Sawada T, Ishida T, Yasue K, Shinoda K, Saito T, Kaburagi T, Kiyoshima M, Okumura T, Sakurai H. Stereotactic Body Radiotherapy for Stage I Lung Cancer With a New Real-time Tumor Tracking System. ANTICANCER RESEARCH, 2022 ; 42(6), 2989-2995.

  Hirotaki K, Moriya S, Tachibana H, Sakae T. Detection of anatomical changes using two-dimensional x-ray images for head and neck adaptive radiotherapy. Med Phys, 2022 ;49(5), 3288-3297.

  Urakawa H, Nagano A, Machida R, Tanaka K, Kataoka T, Sekino Y, Nishida Y, Takahashi M, Kunisada T, Kawano M, Yoshida Y, Takagi T, Sato K, Hiruma T, Hatano H, Tsukushi S, Sakamoto A, Akisue T, Hiraoka K, Ozaki T, Group ObotBaSTTSGotJCO. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610. Jpn J Clin Oncol, 2022 ; Online ahead of print.

  Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito A, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial. Jpn J Clin Oncol, 2022 ; 52(8), 859-868.

  Tony Liang HK, Takei H, Tomita T, Terunuma T, Isobe T, Okumura T, Sakae T, Sakurai H. Analysis of diaphragm movements to specify geometric uncertainties of respiratory gating near end-exhalation for irradiation fields involving the liver dome. Radiother Oncol, 2022 ; 171, 146-154.

  Kim B, Kim GM, Kim E, Park J, Isobe T, Mori Y, Oh S. The Anthropometric Measure 'A Body Shape Index' May Predict the Risk of Osteoporosis in Middle-Aged and Older Korean People. Int J Environ Res Public Health, 2022 ; 19(8).

  Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Yumita S, Nakagawa M, Ishino T, Ogawa K, Fujiwara K, Iwanaga T, Sakuma T, Fujita N, Kojima R, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Ozawa Y, Kawasaki Y, Kurokawa T, Hanaoka H, Tsuji H, Kato N. Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial. BMJ Open, 2022 ; 12(4), e059779.

  Mizumoto M, Oshiro Y, Sumiya T, Miyamoto T, Baba K, Murakami M, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Maruo K, Sakae T, Sakurai H. Olfactory Sensations During Proton and Photon Radiotherapy: A Multicenter Prospective Observational Study. Cureus, 2022 ; 14(3), e22964.

  Hiroshima Y, Tamaki Y, Sawada T, Murakami M, Ishida T, Saito T, Kojima H, Okumura T, Sakurai H. A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion. CANCER DIAGNOSIS & PROGNOSIS,2022 ; 2(2), 258-262.

  Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, Kadoya M, Kudo M, Kumada T, Kokudo N, Sakamoto M, Sakamoto Y, Sakurai H, Takayama T, Nakashima O, Nagata Y, Hatano E, Harada K, Murakami T, Yamamoto M. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma. Liver Cancer,2022 ; 11(4), 290-314.

  Nemoto Murofushi K, Tanaka R, Ohkawa A, Numajiri H, Minakami S, Okumura T, Sakurai H. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation. Journal of Contemporary Brachytherapy, 2022 ; 14(1), 60-65.

  Goto M, Oshiro Y, Tamaki Y, Ishida T, Kato Y, Shinoda K, Sakurai H. A novel method for skin marking in radiotherapy: first clinical use of temporary organic tatoo seal. Journal of Radiation Research, 2022 ; 63(2), 314-318.

  Ishida T, Ohno T, Saito T, Hiroshima Y, Shikama A, Iijima T, Yoshida A, Mizumoto M, Sakurai H, Tamaki Y. A Recurrent Solitary Fibrous Tumor With an Exceptional Response to Low-Dose Radiotherapy: A Case Report and Literature Review. Cureus, 2022 ; 14(1), e21199.

  
  
  

  ▼2021年度

  Mizumoto M, Oshiro Y, Sumiya T, Miyamoto T, Baba K, Murakami M, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Maruo K, Sakae T, Sakurai H. Olfactory Sensations During Proton and Photon Radiotherapy: A Multicenter Prospective Observational Study. Cureus, 2022 ; 14(3), e22964.

  Hiroshima Y, Tamaki Y, Sawada T, Murakami M, Ishida T, Saito T, Kojima H, Okumura T, Sakurai H. A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion. CANCER DIAGNOSIS & PROGNOSIS,2022 ; 2(2), 258-262.

  Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, Kadoya M, Kudo M, Kumada T, Kokudo N, Sakamoto M, Sakamoto Y, Sakurai H, Takayama T, Nakashima O, Nagata Y, Hatano E, Harada K, Murakami T, Yamamoto M. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma. Liver Cancer,2022 ; 11(4), 290-314.

  Nemoto Murofushi K, Tanaka R, Ohkawa A, Numajiri H, Minakami S, Okumura T, Sakurai H. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation. Journal of Contemporary Brachytherapy, 2022 ; 14(1), 60-65.

  Goto M, Oshiro Y, Tamaki Y, Ishida T, Kato Y, Shinoda K, Sakurai H. A novel method for skin marking in radiotherapy: first clinical use of temporary organic tatoo seal. Journal of Radiation Research, 2022 ; 63(2), 314-318.

  Ishida T, Ohno T, Saito T, Hiroshima Y, Shikama A, Iijima T, Yoshida A, Mizumoto M, Sakurai H, Tamaki Y. A Recurrent Solitary Fibrous Tumor With an Exceptional Response to Low-Dose Radiotherapy: A Case Report and Literature Review. Cureus, 2022 ; 14(1), e21199.

  Kim B, Kim G, Kim E, Park J, Isobe T, Sakae T, Oh S. The A Body Shape Index Might Be a Stronger Predictor of Chronic Kidney Disease Than BMI in a Senior Population. Int J Environ Res Public Health,2021 ; 18(24), 12874.

  Shirakawa M, Zaboronok A, Nakai K, Sato Y, Kayaki S, Sakai T, Tsurubuchi T, Yoshida F, Nishiyama T, Suzuki M, Tomida H, Matsumura A. A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy. Cells, 2021 ; 10(12), 3421.

  Mizukami S, Watanabe Y, Mizoguchi T, Gomi T, Hara H, Takei H, Fukunishi N, Ishikawa KL, Fukuda S, Maeyama T. Whole Three-Dimensional Dosimetry of Carbon Ion Beams with an MRI-Based Nanocomposite Fricke Gel Dosimeter Using Rapid T(1) Mapping Method. Gels, 2021 ; 7(4), 233.

  Mizumoto M, Oshiro Y, Miyamoto T, Sumiya T, Murakami M, Baba K, Shimizu S, Iizumi T, Numajiri H, Nakai K, Okumura T, Maruo K, Sakae T, Sakurai H. Light flashes during proton and photon radiotherapy: A multicenter prospective observational study. Technical Innovations & Patient Support in Radiation Oncology,2021 ; 20, 41-45.

  Hashimoto T, Demizu Y, Numajiri H, Isobe T, Fukuda S, Wakatsuki M, Yamashita H, Murayama S, Takamatsu S, Katoh H, Murata K, Kohno R, Arimura T, Matsuura T, Ito YM. Particle therapy using protons or carbon ions for cancer patients with cardiac implantable electronic devices (CIED): a retrospective multi-institutional study. Jpn J Radiol, 2021 ; 40(5), 525-533.

  Shiraishi Y, Hakozaki T, Nomura S, Kataoka T, Tanaka K, Miura S, Sekino Y, Ando M, Horinouchi H, Ohe Y, Okamoto I. A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non-Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study). Clinical lung cancer, 2021 ; Online ahead of print.

  Numajiri H, Mizumoto M, Okumura T, Fukumitsu N, Hasegawa N, Ishige K, Fukuda K, Ishizu T, Tokushige K, Sakurai H. Proton Beam Therapy for Hepatocellular Carcinoma after the Fontan Procedure. Journal of Cancer Therapy, 2021 ; 12(10), 554-562.

  Iizumi T, Ishikawa H, Sekino Y, Tanaka K, Takizawa D, Makishima H, Numajiri H, Mizumoto M, Nakai K, Okumura T, Sakurai H. Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer. Journal of Medical Radiation Sciences, 2021 ; 69(2), 198-207.

  Saito T, Ohnishi K, Ishikawa H, Nakamura M, Hoshiai S, Numajiri H, Nemoto Murofushi K, Mizumoto M, Okumura T, Sakurai H. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease. ANTICANCER RESEARCH, 2021 ; 41, 5635-5642.

  Okawa K, Inoue M, Sakae T. Development of a tracking error prediction system for the CyberKnife Synchrony Respiratory Tracking System with use of support vector regression. Medical & Biological Engineering & Computing,2021 ; 59, 2409-2418.

  Arakawa Y, Sasaki K, Mineharu Y, Uto M, Mizowaki T, Mizusawa J, Sekino Y, Ono T, Aoyama H, Satomi K, Ichimura K, Kinoshita M, Ohno M, Ito Y, Nishikawa R, Fukuda H, Nishimura Y, Narita Y, Group BTS, Radiation Therapy Study Group JCOG. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII). BMC Cancer, 2021 ; 21(1), 1105.

  Sumiya T, Ishikawa H, Hiroshima Y, Nakamura M, Murakami M, Mizumoto M, Okumura T, Sakurai H. The impact of lymphopenia during chemoradiotherapy using photons or protons on the clinical outcomes of esophageal cancer patients. Journal of Radiation Research, 2021 ; 62, 1045-1055.

  Ishibashi A, Kurosaki H, Miura K, Utsumi N, Sakurai H. Influence of Modulation Factor on Treatment Plan Quality and Irradiation Time in Hippocampus-Sparing Whole-Brain Radiotherapy Using Tomotherapy. Technology in Cancer Research & Treatment, 2021 ; 20, 1-6.

  Zaboronok A, Taskaev S, Volkova O, Mechetina L, Kasatova A, Sycheva T, Nakai K, Kasatov D, Makarov A, Kolesnikov I, Shchudlo I, Bykov T, Sokolova E, Koshkarev A, Kanygin V, Kichigin A, Mathis BJ, Ishikawa E, Matsumura A. Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant Tumors. Pharmaceutics, 2021 ; 13(9).

  Miura K, Kurosaki H, Utsumi N. Palliative radiation treatment used for multiple purposes in a single irradiation field. BMJ case reports, 2021 ; 14(9), e244172.

  Nakayama M, Ohnishi K, Adachi M, Ii R, Matsumoto S, Nakamura M, Miyamoto H, Hirose Y, Nishimura B, Tanaka S, Wada T, Tabuchi K. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy. Auris Nasus Larynx, 2022 ; 49(2), 279-285.

  Hsinag-Kuang TL, Mizumoto M, Ishikawa E, Matsuda M, Tanaka K, Kohzuki H, Numajiri H, Oshiro Y, Okumura T, Matsumura A, Sakurai H. Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost. J Cancer Res Clin Oncol, 2021 ; 147(12), 3503-3516.

  Matsumoto Y, Fukumitsu N, Ishikawa H, Nakai K, Sakurai H. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond. Journal of Personalized Medicine, 2021 ; 11(8), 825.

  Fukumitsu N, Matsumoto Y. Development of an Imaging Technique for Boron Neutron Capture Therapy. cells, 2021 ; 10(8), 2135.

  Hongo H, Tokuue K, Sakae T, Mase M, Omura M. Robust Treatment Planning in Intrafraction Motion Using TomoDirect™ Intensity-modulated Radiotherapy for Breast Cancer. in vivo, 2021 ; 35(5), 2655-2659.

  Mizumoto M, Liang HK, Oshiro Y, Matsuda M, Kohzuki H, Iizumi T, Numajiri H, Nakai K, Okumura T, Ishikawa E, Sakurai H. Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis. Cureus, 20221 ; 13(8), e16887.

  石田真也, 川村拓, 佐藤勝, 榮武二. ポリマーゲル線量計を用いた陽子線パッチ照射野検証に関する検討. 日本放射線技術学会雑誌, 2021 ; 77(8), 811-820.

  Sato T, Hashimoto S, Inaniwa T, Takada K, Kumada H. Implementation of simplified stochastic microdosimetric kinetic models into PHITS for application to radiation treatment planning. International Journal of Radiation Biology, 2021 ; 97(10), 1450-1460.

  Ishikawa E, Sugii N, Matsuda M, Kohzuki H, Tsurubuchi T, Akutsu H, Takano S, Mizumoto M, Sakurai H, Matsumura A. Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospectivesingle-institution prognostic analysis. BMC Neurology, 2021 ; 21(282), 1-10.

  Yoshida R, Koroki K, Makishima H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Fujita N, Sakuma T, Kanzaki H, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kaneko T, Wakatsuki M, Kato J, Tsujii H, Kato N. Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma. Case Reports in Oncology, 2021 ; 14(2), 1103-1110.

  Ogawa K, Ishikawa H, Hisakura K, Hiroshima Y, Moriwaki T, Yamada T, Yamamoto Y, Akashi Y, Owada Y, Ohara Y, Enomoto T, Furuya K, Doi M, Shimomura O, Takahashi K, Hashimoto S, Sakurai H, Oda T. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma. International Journal of Clinical Oncology, 2021 ; 26, 1856-1863.

  Hiroshima Y, Ishikawa H, Murakami M, Nakamura M, Shimizu S, Enomoto T, Oda T, Mizumoto M, Nakai K, Okumura T, Sakurai H. Proton Beam Therapy for Local Recurrence of Rectal Cancer. ANTICANCER RESEARCH, 2021 ; 41(7), 3589-3595.

  Shimomura A, Tamura K, Tanaka K, Mizutani T, Sasaki K, Sekino Y, Sawaki M, Shien T, Shibata T, Iwata H, on behalf of the Breast Cancer Study Group of the Japanese Clinical Oncology Group. A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study). Japanese Journal of Clinical Oncology,2021 ; 2021(9), 1471-1474.

  Murofushi Nemoto K, Tomita T, Ohnishi K, Nakai K, Akiyama A, Saida Sasaki T, Okumura T, Karasawa K, Satoh T, Sakurai H. Risk Factors for Venous Thromboembolism Induced by Prolonged Bed Rest during Interstitial Brachytherapy for Gynecological Cancer: A Retrospective Study. Research Square, 2021 ; 1-17.

  Fujisawa N, Takanohashi M, Chen L, Uto K, Matsumoto Y, Takeuchi M, Ebara M. A Diels-Alder polymer platform for thermally enhanced drug release toward efficient local cancer chemotherapy. Sci Technol Adv Mater,2021 ; 22(1), 522-531.

  Nemoto Murofushi K, Tanaka R, Ohkawa A, Numajiri H, Okumura T, Sakurai H. Outcomes and dose-volume parameters for computed tomography-based brachytherapy planning for vaginal recurrence of uterine cancer primarily treated with surgery. Clinical and Experimental Obstetrics & Gynecology, 2021 ; 48(3), 601-606.

  Oshiro Y, Mizumoto M, Sekino Y, Maruo K, Ishida T, Sumiya T, Nakamura M, Ohkawa A, Takizawa D, Okumura T, Tamaki Y, Sakurai H. Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan. Clinical and Translational Radiation Oncology, 2021 ; 29, 54-59.

  Iizumi T, Okumura T, Sekino Y, Takahashi H, Tsai YL, Takizawa D, Ishida T, Hiroshima Y, Nakamura M, Shimizu S, Saito T, Numajiri H, Mizumoto M, Nakai K, Sakurai H. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma. Journal of Radiation Research, 2021 ; 62(4), 682-687.

  Nakamura M, Ishikawa H, Ohnishi K, Mori Y, Baba K, Nakazawa K, Shiozawa T, Sekine I, Maruo K, Okumura T, Sakurai H. Analysis of the Association Between Low Dose Bone, Lung, and Heart Irradiation and Survival Rates for Patients Who Received High-dose Proton Beam Therapy With Concurrent Chemotherapy for Stage III Non-small Cell Lung Cancer. Research Square, 2021 ; 1-22.

  Ohnishi K, Misawa M, Sikano N, Nakai K, Suzuki M. Enhancement of Cancer Cell-Killing Effects of Boron Neutron Capture Therapy by Manipulating the Expression of L-Type Amino Acid Transporter 1. Radiat Res, 2021 ; 196(1), 17-22.

  Mizumoto M, Oshiro Y, Tsujino K, Shimizu S, Iizumi T, Numajiri H, Nakai K, Okumura T, Soejima T, Sakurai H. Photon or Proton Therapy for Adolescent and Young Adult Tumors Focused on Long-Term Survivors. Cureus, 2021 ; 13(4), e14627.

  Suzuki R, Fukushima H, Okuwaki H, Inaba M, Hosaka S, Yamaki Y, Fukushima T, Masumoto K, Mizumoto M, Sakurai H, Takada H. Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma. Reports of Practical Oncology and Radiotherapy, 2021 ; 26(4), 616-625.

  Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, Demizu Y, Iwata H, Hashimoto T, Motegi A, Kawamura A, Terashima K, Fukushima T, Nakao T, Takada A, Sumi M, Oshima J, Moriwaki K, Nozaki M, Ishida Y, Kosaka Y, Ae K, Hosono A, Harada H, Ogo E, Akimoto T, Saito T, Fukushima H, Suzuki R, Takahashi M, Matsuo T, Matsumura A, Masaki H, Hosoi H, Shigematsu N, Sakurai H. Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines. Cancer Treatment Reviews, 2021 ; 98, 102209.

  Sato H, Mizumoto M, Okumura T, Sakurai H, Sakamoto N, Akutsu H, Ishikawa E, Tsuboi K. Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy. Journal of Radiation Research, 2021 ; 62(3), 427-437.

  
  
  

  ▼2020年度

  Aibe N, Ogino H, Teramukai S, Yamazaki H, Iwata H, Matsuo Y, Okimoto T, Murakami M, Suzuki M, Arimura T, Ogino T, Murayama S, Harada S, Nakamura M, Akimoto T, Saskurai H. Multi-Institutional Retrospective Analysis of the Outocomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers. Advances in Radiation Oncology, 2021; 6(4): 100690.

  Hirayama R, Ito A, Uzawa A, Matsumoto Y, Noguchi M, Li H, Suzuki M, Ando K, Okayasu R, Hasegawa S, Furusawa Y. Lethal DNA Lesions Caused by Direct and Indirect Actions of X rays are Repaired via Different DSB Repair Pathways under Aerobic and Anoxic Conditions. Radiat Res, 2021; 195(5) : 441-451.

  Shimomura O, Oda T, Hashimoto S, Doi M, Hiroshima Y, Numajiri H, Takahashi K, Furuya K, Miyazaki Y, Owada Y, Ogawa K, Ohara Y, Hisakura K, Akashi Y, Enomoto T, Sakurai H. Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma. Surgical Oncology, 2021; 37: 101542.

  Ohnishi K, Ishikawa H, Nakazawa K, Shiozawa T, Mori Y, Nakamura M, Okumura T, Sekine I, Hizawa N, Sakurai H. Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer. Thoracic Cancer, 2021; Online ahead of print.

  Miura K, Kurosaki H, Utsumi N, Sakurai H. Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy. Technology in Cancer Research & Treatment, 2021; 20 : 1-5.

  Nemoto Murofushi K, Ishida T, Baba K, Kawakita K, Saida T, Okumura T, Satoh T, Sakurai H. Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy, 2021; 13(1) : 32-38.

  Czerska K, Emert F, Kopec R, Langen K, McClelland JR, Meijers A, Miyamoto N, Riboldi M, Shimizu S, Terunuma T, Zou W, Knopf A, Rucinski A. Clinical practice vs. state-of-the-art research and future visions: Report on the 4D treatment planning workshop for particle therapy - Edition 2018 and 2019. Phys Med, 2021; 82 : 54-63.

  Shimizu S, Mizumoto M, Okumura T, Li Y, Baba K, Murakami M, Ishida T, Nakamura M, Hiroshima Y, Iizumi T, Saito T, Numajiri H, Nakai K, Hata M, Sakurai H. Proton beam therapy for a giant hepatic hemangioma: A case report and literature review. Clin Transl Radiat Oncol, 2021 ; 27 : 152-156.

  Baba K, Mizumoto M, Oshiro Y, Shimizu S, Nakamura M, Hiroshima Y, Iizumi T, Saito T, Numajiri H, Nakai K, Ishikawa H, Okumura T, Maruo K, Sakurai H. An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer. Cancers, 2021; 13(2) : 349.

  Sekino Y, Ishikawa H, Kimura T, Kojima T, Maruo K, Azuma H, Yoshida K, Kageyama Y, Ushijima H, Tsuzuki T, Sakurai H, Nishiyama H. Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter study. Contemporary Clinical Trials Communications, 2021; 21: 100724.

  Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, Uno T, Tokumaru S, Harima Y, Gomi H, Toita T, Kita M, Noda SE, Takahashi T, Kato S, Ohkawa A, Tozawa-Ono A, Ushijima H, Hasumi Y, Hirashima Y, Niibe Y, Nakagawa T, Akita T, Tanaka J, Ohno T, (JROSG) WGotGTCotJROSG. A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan. J Radiat Res, 2021 ; 62(2): 269-284TRIO.

  Islam W, Matsumoto Y, Fang J, Harada A, Niidome T, Ono K, Tsutsuki H, Sawa T, Imamura T, Sakurai K, Fukumitsu N, Yamamoto H, Maeda H. Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis. Biomaterials, 2021; 269, 120631.

  Sawada T, Mizumoto M, Oshiro Y, Numajiri H, Shimizu S, Hiroshima Y, Nakamura M, Iizumi T, Okumura T, Sakurai H. Long-term follow up of a patient with a recurrent desmoid tumor that was successfully treated with proton beam therapy: A case report and literature review. Clinical and Translational Radiation Oncology, 2020; 27(2021): 32-35.

  Iwasaki T, Mizumoto M, Numajiri H, Oshiro Y, Suzuki R, Moritani K, Eguchi M, Ishii E, Sakurai H. Re-irradiation using proton therapy for radiation-induced secondary cancer with Li-Fraumeni syndrome: A case report and review of literature. Journal of Cancer Research and Therapeutics, 2020; 16(6), 1524-1527.

  Kim A, Suzuki M, Matsumoto Y, Fukumitsu N, Nagasaki Y. Non-isotope enriched phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drug. Biomaterials, 2020; 268 :120551.

  Hidaka K, Fukushima H, Hosaka S, Muroi A, Yamamoto T, Mizumoto M, Sakurai H, Takada H. Cognitive Functions of Pediatric Brain Tumor Survivors Treated With Proton Beam Therapy: A Case Series. J Pediatr Hematol Oncol, 2020; 43(8) : e1205-e1209.

  Tsai YL, Takei H, Iizumi T, Okumura T, Sekino Y, Numajiri H, Ishikawa H, Sakae T, Sakurai H. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma. Journal of Radiation Research, 2020; 62(1) : 133-141.

  Oshiro Y, Mizumoto M, Pan H, Kaste SC, Gajjar A, Merchant TE. Spinal changes after craniospinal irradiation in pediatric patients. Pediatr Blood Cancer, 2020; 67(12): 228728.

  Takada K, Sato T, Kumada H, Sakurai H, Sakae T. Evaluation of RBE-weighted doses for various radiotherapy beams based on a microdosimetric function implemented in PHITS. Journal of Physics: Conference Series, MMND ITRO 2020, 2020; 1662: 012004.

  Kumada H, Takada K, Sato T, Sakurai H, Sakae T. Multimodal Monte Carlo treatment system capable of microdosimetry with PHITS. Journal of Physics: Conference Series, MMND ITRO 2020, 2020 ; 1662 : 012020.

  Kimura T, Ishikawa H, Kojima T, Kandori S, Kawahara T, Sekino Y, Sakurai H, Nishiyama H. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Jpn J Clin Oncol, 2020 ; 50(10) : 1097-1107.

  Fukumitsu N, Ishikawa H, Arimura T, Wada H, Okimoto T, Sato Y, Iwata H, Shimizu S, Sakurai H. Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan. In Vivo, 2020 ; 34(5) : 2883-2889.

  Vares G, Jallet V, Matsumoto Y, Rentier C, Takayama K, Sasaki T, Hayashi Y, Kumada H, Sugawara H. Functionalized mesoporous silica nanoparticles for innovative boron-neutron capture therapy of resistant cancers. Nanomedicine, 2020; 27 :102195.

  Mizumoto M, Oshiro Y, Pan H, Wang F, Kaste SC, Gajjar A, Chemaitilly W, Merchant TE. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors. Pediatr Blood Cancer, 2020; 67(10) : e28617.

  Nakai K, Endo K, Yoshida F, Koka M, Yamada N, Satoh T, Tsurubuchi T, Matsumura A, Matsumoto Y, Sakurai H. Boron analysis and imaging of cells with 2-hr BPA exposure by using micro-proton particle-induced gamma-ray emission (PIGE). Appl Radiat Isot, 2020 ; 165 : 109334 (109331-109336).

  Negoro H, Iizumi T, Mori Y, Matsumoto Y, Chihara I, Hoshi A, Sakurai H, Nishiyama H, Ishikawa H. Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms. J Clin Med, 2020; 9(7) : 2263.

  Sumiya T, Mizumoto M, Oshiro Y, Baba K, Murakami M, Shimizu S, Nakamura M, Hiroshima Y, Ishida T, Iizumi T, Saito T, Numajiri H, Nakai K, Okumura T, Sakurai H. Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma. Cancers (Basel), 2020; 12(7) : 1840.

  Takada K, Kumada H, Matsumura A, Sakurai H, Sakae T. Computational evaluation of dose distribution for BNCT treatment combined with X-ray therapy or proton beam therapy. Appl Radiat Isot, 2020; 165 : 109295.

  Kumada H, Takada K, Aihara T, Matsumura A, Sakurai H, Sakae T. Verification for dose estimation performance of a Monte-Carlo based treatment planning system in University of Tsukuba. Appl Radiat Isot,2020 ;166 : 109222.

  Shirakawa M, Nakai K, Sato Y, Nakamura S, Harada M, Ishikawa K, Yoshida F, Matsumura A, Tomida H. Optimization of preparation methods for high loading content and high encapsulation efficiency of BSH into liposomes. Applied Radiation and Isotopes, 2020 ;169 : 109260.

  Nakamura M, Ohnishi K, Ishikawa H, Nakazawa K, Shiozawa T, Okumura T, Sekine I, Sato Y, Hizawa N, Sakurai H. Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer. In Vivo, 2020; 34(4) : 1883-1892.

  Kumada H, Takada K, Tanaka S, Matsumoto Y, Naito F, Kurihara T, Sugimura T, Sato M, Matsumura A, Sakurai H, Sakae T. Evaluation of the characteristics of the neutron beam of a linac-based neutron source for boron neutron capture therapy. Appl Radiat Isot, 2020 ; 165 : 109246.

  Murakami M, Ishikawa H, Shimizu S, Iwata H, Okimoto T, Takagi M, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Gosho M, Nakamura K, Sakurai H. Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers (Basel),2020 ; 12(6) : 1690.

  Yoshida F, Kurita T, Endo K, Nakai K, Shirakawa M, Zaboronok A, Tsurubuchi T, Ishikawa E, Matsumura A. Difference in BPA uptake between glioma stem-like cells and their cancerous cells. Appl Radiat Isot, 2020 ; 164 : 109234.

  Tsurubuchi T, Shirakawa M, Kurosawa W, Matsumoto K, Ubagai R, Umishio H, Suga Y, Yamazaki J, Arakawa A, Maruyama Y, Seki T, Shibui Y, Yoshida F, Zaboronok A, Suzuki M, Sakurai Y, Tanaka H, Nakai K, Ishikawa E, Matsumura A. Evaluation of a Novel Boron-Containing alpha-D-Mannopyranoside for BNCT. Cells, 2020; 9(5).

  Kumada H, Takada K, Terunuma T, Aihara T, Matsumura A, Sakurai H, Sakae T. Monitoring patient movement with boron neutron capture therapy and motion capture technology. Applied Radiation and Isotopes, 2020 ; 163 : 1-6.

  Matsumoto Y, Hattori K, Arima H, Motoyama K, Higashi T, Ishikawa H, Fukumitsu N, Aihara T, Nakai K, Kumada H, Sakurai H. Folate-appended cyclodextrin improves the intratumoral accumulation of existing boron compounds. Applied Radiation and Isotopes, 2020; 163 : 6.

  Murofushi K, Yoshioka Y, Sumi M, Ishikawa H, Oguchi M, Sakurai H. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer. Int J Gynecol Cancer, 2020 ; 30(4) : 473-479.

  
  
  

  ▼2019年度

  Kumada H, Tanaka S, Naito F, Kurihara T, Sugimura T, Sakurai H, Matsumura A, Sakae T. Neutron beam performance of iBNCT as linac-based neutron source for boron neutron capture therapy. EPJ Web of Conference, 2020 ; 231(01003) : 1-4.

  Darwis NDM , Oike T, Kawamura H, Kawahara M, Kubom N, Sato H, Miyasaka Y, Katoh H, Ishikawa H , Matsui H, Miyazawa Y, Ito K, Suzuki K, Gondhowiardjo S, Nakano T, Ohno T. Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer. Cancers (Basel). 2020;12(3):E589（8ページ）;doi:10.3390/cancers12030589

  Inoue Y, Yamagata K, Nakamura M, Ohnishi K, Tabuchi K, Bukawa H. Are Intraoral Stents Effective for Reducing the Severity of Oral Mucositis During Radiotherapy for Maxillary and Nasal Cavity Cancer? J Oral Maxillofac Surg,2020; 78(7), 1214.e1211-1214.e1218.

  Murofushi KN, Yoshioka Y, Ishikawa H, Sumi M, Okumura T, Oguchi M, Sakurai H. Selection Criteria and Clinical Outcomes of Patients With Asymmetrical Cervical Cancer Treated With Various High-dose-rate Brachytherapy Techniques. Anticancer Res, 2020 ; 40(2) : 999-1006.

  Kawamura H, Kubo N, Sato H, Mizukami T, Katoh H, Ishikawa H, Ohno T, Matsui H, Ito K, Suzuki K, Nakano T, Group for Genitourinary Tumors at Gunma University Heavy Ion Medical Center. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702". BMC Cancer. 2020;20(1):75;doi:10.1186/s12885-020-6570-8.

  Tanaka K, Matsumoto Y, Ishikawa H, Fukumitsu N, Numajiri H, Murofushi K, Oshiro Y, Okumura T, Satoh T, Sakurai H. Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy. J Radiat Res, 2020 ; 61(2) : 221-230.

  Okumura T, Makishima H, Sakurai H. Key considerations in reviewing "a comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma": the importance of scientific objective perspectives in clinical studies. Surg Today. 2020:1-2;doi:10.1007/s00595-020-01961-4.

  Shimizu S, Okumura T, Oshiro Y, Fukumitsu N, Fukuda K, Ishige K, Hasegawa N, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Nonaka T, Ishikawa H, Sakurai H. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy. Radiat Oncol. 2019;14(1):241;doi:10.1186/s13014-019-1451-5.

  松田尚樹, 浦田芳重, 北川昌伸, 青木昌彦, 細井義夫, 根本健二, 大津留晶, 磯辺智範, 櫻井英幸, 宮川清, 吉村亮一, 神田玲子, 近藤隆, 武田俊一, 藤堂剛, 粟井和夫, 續輝久, 永安武. 放射線健康リスク科学教育の現状と課題　~全国実態調査の結果より~. 医学教育 2019;50 (6):581-7.

  Kobayashi D, Isobe T, Takada K, Mori Y, Takei H, Kumada H, Kamizawa S, Tomita T, Sato E, Yokota H, Sakae T. Establishment of a New Three-Dimensional Dose Evaluation Method Considering Variable Relative Biological Effectiveness and Dose Fractionation in Proton Therapy Combined with High-Dose-Rate Brachytherapy. J Med Phys. 2020;44(4):270-5;doi:10.4103/jmp.JMP_117_18.

  Sekino Y, Okumura T, Fukumitsu N, Iizumi T, Numajiri H, Mizumoto M, Nakai K, Nonaka T, Ishikawa H, Sakurai H. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J Cancer Res Clin Oncol. 2019;146(3):711-20;doi:10.1007/s00432-019-03096-7.

  Murakami M, Fukumitsu N, Okumura T, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Ishikawa H, Tsuboi K, Sakurai H. Three cases of hepatocellular carcinoma treated 4 times with proton beams. Molecular and clinical oncology. 2019;12(1):31-5;doi:10.3892/mco.2019.1950.

  Muroi A, Mizumoto M, Ishikawa E, Ihara S, Fukushima H, Tsurubuchi T, Sakurai H, Matsumura A. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma. Childs Nerv Syst. 2019;36(3):507-12;doi:10.1007/s00381-019-04420-9.

  Takahashi H, Sekino Y, Mori K, Okumura T, Nasu K, Fukuda K, Masuoka S, Iizumi T, Hasegawa N, Sakurai H, Minami M. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT. Br J Radiol. 2019;93(1105):20190375;doi:10.1259/bjr.20190375.

  Inaba M, Nakao T, Hosaka S, Suzuki R, Fukushima H, Yamaki Y, Saito T, Sakashita S, Noguchi M, Minami M, Masumoto T, Mizumoto M, Sakurai H, Fukushima T, Takada H. Urgent Proton Beam Therapy With Interinstitutional Transfer for Patients With Intracranial Rhabdomyosarcoma: Report of 3 Cases. J Pediatr Hematol Oncol. 2019;42(1):e12-7;doi:10.1097/MPH.0000000000001620.

  Nagumo Y, Kojima T, Shiga M, Kandori S, Kimura T, Takaoka E. I, Onozawa M, Miyazaki J, Kawai K, Ishikawa H, Sakurai H, Nishiyama H. A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma. Int J Clin Oncol. 2019;25(2):354-61;doi:10.1007/s10147-019-01553-4.

  Ohnishi K, Nakamura N, Harada H, Tokumaru S, Wada H, Arimura T, Iwata H, Sato Y, Sekino Y, Tamamura H, Mizoe J. E, Ogino T, Ishikawa H, Kikuchi Y, Okimoto T, Murayama S, Akimoto T, Sakurai H. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan. Int J Radiat Oncol Biol Phys. 2019;106(1):82-9;doi:10.1016/j.ijrobp.2019.09.013.

  Koketsu J, Kumada H, Takada k, Takei H, Mori, Y, Kamizawa S, Hu Yuchao, Sakurai H, Sakae T. 3D-printable lung phantom for distal falloff verification of proton Bragg peak. J Appl Clin Med Phys. 2019;20(9):86-94;doi:10.1002/acm2.12706.

  Konishi T, Shinozaki E, Murofushi K, Taguchi S, Fukunaga Y, Nagayama S, Fujimoto Y, Akiyoshi T, Nagasaki T, Suenaga M, Chino A, Kawachi H, Yamamoto N, Ishikawa Y, Oguchi M, Ishizuka N, Ueno M, Yamaguchi K. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer. Ann Surg Oncol. 2019;26(8):2507-13;doi:10.1245/s10434-019-07342-7.

  Hosaka S, Fukushima H, Nakao T, Suzuki R, Yamaki Y, Tanaka K, Saito T, Mizumoto M, Sakurai H, Fukushima T, Takada H. Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma. J Pediatr Hematol Oncol. 2019;42(1):e18-e24;doi:10.1097/MPH.0000000000001570.

  Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, Nagano H, Hatano E, Izumi N, Kaneko S, Kudo M, Iijima H, Genda T, Tateishi R, Torimura T, Igaki H, Kobayashi S, Sakurai H, Murakami T, Watadani T, Matsuyama Y. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019;49(10):1109-13;doi:10.1111/hepr.13411.

  Ishikawa H, Tsuji H, Murayama S, Sugimoto M, Shinohara N, Maruyama S, Murakami M, Shirato H, Sakurai H. Particle therapy for prostate cancer: The past, present and future. Int J Urol. 2019;26(10):971-9;doi:10.1111/iju.14041.

  Ogasawara Y, Kogiso T, Sagawa T, Kodama K, Taniai M, Numajiri H, Sakurai H, Tokushige K. A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy. Clinical Journal of Gastroenterology. 2020;13(1):73-8:Epub2020.02:2020.02:year;doi:10.1007/s12328-019-01010-9.

  Ono T, Wada H, Ishikawa H, Tamamura H, Tokumaru S. Clinical Results of Proton Beam Therapy for Esophageal Cancer: Multicenter Retrospective Study in Japan. Cancers (Basel). 2019;11(7):Epub2019.7:2019.7:year;doi:10.3390/cancers11070993;31315281.

  Iizumi T, Shimizu S, Numajiri H, Takei H, Yamada N, Mizumoto M, Ishikawa H, Okumura T, Sakurai H. Large Malignant Fibrous Histiocytoma Treated with Hypofractionated Proton Beam Therapy and Local Hyperthermia. Int J Particle Therapy. 2019;6(1):35-41;doi:10.14338/IJPT-18-00046.1

  Hiroshima Y, Fukumitsu N, Saito T, Numajiri H, Murofushi KN, Ohnishi K, Nonaka T, Ishikawa H, Okumura T, Sakurai H. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Radiotherapy and Oncology. 2019;136:37-43;doi:org/10.1016/j.radonc.2019.03.012.

  Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima T. E, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2019;doi:10.1007/s10147-019-01485-z.

  Takahashi H, Mori K, Sekino Y, Okumura T, Hiyama T, Fukuda K, Hasegawa N, Sakai M, Kikuchi S, Takei Y, Iizumi T, Sakurai H, Minami M. Angiographic Findings in patients with Hepatocellular Carcinoma Previously treated Using Proton Beam Therapy. Jaunal of Oncology. 2019:1-7;doi:10.1155/2019/3580379.

  Chuong M. D, Kaiser A, Khan F, Parikh P, Ben-Josef E, Crane C, Brunner T, Okumura T, Schreuder N, Bentzen S. M, Gutierrez A, Mendez Romero A, Yoon S. M, Sharma N, Kim T. H, Kishi K, Moeslein F, Hoffe S, Schefter T, Hanish S, Scorsetti M, Apisarnthanarax S. Consensus Report From the Miami Liver Proton Therapy Conference. Front Oncol. 2019;9:457;doi:10.3389/fonc.2019.00457.

  Iizumi T, Ishikawa H, Sekino Y, Ohnishi K, Mizumoto M, Nonaka T, Sakurai H. Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review. Molecular and clinical oncology. 2019;11:24-30;doi:10.3892/mco.2019.1861.

  Takei H, Inaniwa T. Effect of Irradiation Time on Biological Effectiveness and Tumor Control Probability in Proton Therapy. International Journal of Radiation Oncology*Biology*Physics. 019;105(1);doi:https://doi.org/10.1016/j.ijrobp.2019.05.004.

  Matsumoto Y, Furusawa Y, Aoki-Nakano M, Matsufuji N, Hirayama R, Kanai T, Ando K, Sakurai H. Estimation of Rbe Values for Carbon-Ion Beams in the Wide Dose Range Using Multicellular Spheroids. Radiat Prot Dosimetry. 2019;183(1-2):45-9;doi:10.1093/rpd/ncy269.

  Furusawa Y, Matsumoto Y, Hirayama R, Ohsawa D, Konishi T. Dose-Rate and Cell-Killing Sensitivity of High-Linear Energy Transfer Ion Beam. Radiat Prot Dosimetry. 2019;183(1-2):219-22;doi:10.1093/rpd/ncy267.

  
  
  

  ▼2018年度

  Ebara T, Ando K, Eishima J, Suzuki M, kawakami T, Horikoshi H, Tamaki Y. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Japanese Journal of Radiology. 2019;37(6):494-9;doi:10.1007/s11604-019-00827-1.

  Mizumoto M, Oshiro Y, Sakurai H. Significance of indocyanine green test in radiotherapy for hepatocellular carcinoma. Translational Cancer Research, 2019; 8(1): 14-16.

  Yamagata K, Ishikawa H, Saito T, Bukawa H. Proton Beam Therapy for Ameloblastic Carcinoma of the Maxilla: Report of a Rare Case. J Oral Maxillofac Surg, 2019 ; 77(1) : 227.e221-227.e225.

  Matsumoto Y, Ando K, Kato TA, Sekino Y, Ishikawa H, Sakae T, Tsuboi K, Sakurai H. Difference in Degree of Sub-Lethal Damage Recovery between Clinical Proton Beams and X-Rays. Radiat Prot Dosimetry, 2018; 183(1-2) : 93-97.

  野中哲生. Ⅲ期非小細胞肺癌・肺尖部胸壁浸潤癌. 日本肺癌学会. 肺癌診療ガイドライン2018年版 第5版 Ⅱ.非小細胞肺癌 (NSLCL). 第5版 東京: 金原出版; 2018. p. 124-141.

  石川仁. 1. 限局型小細胞肺癌（LD-SCLC）. 日本肺癌学会. 肺癌診療ガイドライン2018年版 第5版 第5版 東京: 金原出版; 2018. p. 237-267.

  Murofushi KN, Nakajima M, Tomita T, Sumi M, Yoshioka Y, Oguchi M, Sakurai H. Impact of visual feedback on dose-volume histograms for organs at risk in postoperative radiotherapy with deep inspiration breath-holding for patients treated with breast-conserving therapy: a planning study. Breast Cancer, 2018 ; 25(6) : 656-662.

  Wang Y, Zenkoh J, Gerelchuluun A, Sun L, Cai S, Li X, Tsuboi K. Administration of dendritic cells and anti-PD-1 antibody converts X-ray irradiated tumors into effective in situ vaccines. Int J Radiat Oncol Biol Phys, 2018 ; 103(4) : 958-969.

  兼安裕子, 藤原久也, 西村哲夫, 加藤真吾, 大野達也, 櫻井英幸, 緒本智子, 生島仁史, 宇野隆, 徳丸直郎, 播磨洋子, 五味弘道, 喜多みどり, 野田真永, 高橋健夫, 新部譲, 戸板孝文. 子宮頸癌患者に対する日本語版QOL調査票の開発. 日本婦人科腫瘍学会雑誌, 2018 ; 36(4) : 682-691.

  Matsumoto Y, Furusawa Y, Uzawa A, Hirayama R, Koike S, Ando K, Tsuboi K, Sakurai H. Antimetastatic Effects of Carbon-Ion Beams on Malignant Melanomas. Radiat Res, 2018 ; 190(4) : 412-423.

  Nakao T, Fukushima H, Fukushima T, Suzuki R, Hosaka S, Yamaki Y, Kobayashi C, Iwabuchi A, Imagawa K, Sakai A, Shinkai T, Masumoto K, Sakashita S, Masumoto T, Mizumoto M, Sumazaki R, Sakurai H. Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2018 ; 23(5) : 442-450.

  Nakamura M, Fukumitsu N, Kamizawa S, Numajiri H, Murofushi KN, Ohnishi K, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Sakurai H. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma. J Radiat Res, 2018; 59(5): 632-638.

  Murofushi KN, Kitamura N, Yoshioka Y, Sumi M, Ishikawa H, Oguchi M, Sakurai H. A Clinical Evaluation of American Brachytherapy Society Consensus Guideline for Bulky Vaginal Mass in Gynecological Cancer. Int J Gynecol Cancer, 2018 ; 28(7), 1438-1445.

  Kumada H, Takada K, Sakurai Y, Suzuki M, Takata T, Sakurai H, Matsumura A, Sakae T. Development of a Multimodal Monte Carlo Based Treatment Planning System. Radiat Prot Dosimetry, 2018 ; 180(1-4), 286-290.

  Fukumitsu N, Takahashi S, Okumura T, Ishida T, Murofushi K, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Normal liver tissue change after proton beam therapy. Jpn J Radiol, 2018 ; 36, 559-565.

  Miyazaki T, Sohda M, Sakai M, Kumakura Y, Yoshida T, Kuriyama K, Yokobori T, Miyazaki M, Hirato J, Okumura T, Ishikawa H, Sakurai H, Kuwano H. Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases. Intern Med, 2018 ; 57(16), 2333-2339.

  Hirai K, Wang Z, Miura K, Hayashi T, Awasaki T, Wada M, Keira Y, Ishikawa HO, Sawamura K. Genetic Analyses of Elys Mutations in Drosophila Show Maternal-Effect Lethality and Interactions with Nucleoporin Genes. G3 (Bethesda), 2018 ; 8(7), 2421-2431.

  Taskaev SY, Kanygin VV, Byvaltsev VA, Zaboronok AA, Volkova OY, Mechetina LV, Taranin AV, Kichigin AI, Iarullina AI, Eliseenko IA, Nakai K, Sato E, Yamamoto T, Ishikawa E, Matsumura A. Opportunities for Using an Accelerator-Based Epithermal Neutron Source for Boron Neutron Capture Therapy. Biomedical Engineering, 2018 ; 52(2), 73-76.

  Fukumitsu N, Okumura T, Hiroshima Y, Ishida T, Numajiri H, Murofushi KN, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers. Jpn J Radiol, 2018 ; 36(7), 456-461.

  穂坂翔, 城戸崇裕, 八牧愉二, 福島紘子, 小林千恵, 福島敬, 小野健太郎, 新開統子, 増本幸二, 櫻井英幸, 須磨崎亮. 緊急精巣固定術により精巣被曝を回避して全腹放射線照射を実施した移動性精巣合併Wilms腫瘍の一例. 日本小児血液・がん学会雑誌, 2018 ; 55(1), 37- 40.

  Ohguri T, Harima Y, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial. Int J Hyperthermia, 2018 ; 34(4), 461-468.

  Igaki H, Mizumoto M, Okumura T, Hasegawa K, Kokudo N, Sakurai H. A systematic review of publications on charged particle therapy for hepatocellular carcinoma. Int J Clin Oncol, 2018 ; 23(3), 423-433.

  Sun L, Inaba Y, Sato K, Hirayama A, Tsuboi K, Okazaki R, Chida K, Moritake T. Dose-dependent decrease in anti-oxidant capacity of whole blood after irradiation: A novel potential marker for biodosimetry. Scientific reports, 2018 ; 8(1), 7425.

  Takei H, Isobe T, Kitamura N, Mori Y, Tomita T, Kobayashi D, Kamizawa S, Sato T, Sakurai H, Sakae T. General ion recombination effect in a liquid ionization chamber in high-dose-rate pulsed photon and electron beams. J Radiat Res, 2018 ; 59(3), 282-285.

  Fukumitsu N, Mima M, Demizu Y, Suzuki T, Soejima T, Nonaka T, Okumura T, Sakurai H. Development of radiotherapy for liver cancer. Annals of Gastroenterology and the Digestive System/MedDocs Publishers, 2018 ; 1-3.

  Matsuda M, Kohzuki H, Ishikawa E, Yamamoto T, Akutsu H, Takano S, Mizumoto M, Tsuboi K, Matsumura A. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma. J Clin Neurosci, 2018 ; 50, 172-176.

  
  
  

  ▼2017年度

  Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H. Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan. Cancer Med, 2018 ; 7(5), 1870-1874.

  Sato E, Zaboronok A, Yamamoto T, Nakai K, Taskaev S, Volkova O, Mechetina L, Taranin A, Kanygin V, Isobe T, Mathis BJ, Matsumura A. Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy. J Radiat Res, 2018 ; 59(2), 101-107.

  Iwata H, Ishikawa H, Takagi M, Okimoto T, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Araya M, Mizoe JE, Gosho M, Nakamura K, Shirato H, Sakurai H. Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group. Cancer Med, 2018 ; 7(3), 677-689.

  Fukumitsu N, Yeh. SH-H, II. LGF, Mukhopadhyay. U, Young. D, Ogawa K, Jeong. H-J, Tong. W, Gelovani. JG. In Vivo 6-([18F]Fluoroacetamido)-1-hexanoicanilide PET Imaging of Altered Histone Deacetylase Activity in Chemotherapy-Induced Neurotoxicity. Contrast Media & Molecular Imaging, 2018 ; 12.

  Gerelchuluun A, Maeda J, Manabe E, Brents CA, Sakae T, Fujimori A, Chen DJ, Tsuboi K, Kato TA. Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure. Int J Mol Sci, 2018 ; 19(2), 496-518.

  Nakajima M, Kato H, Muroi H, Kikuchi M, Takahashi M, Yamaguchi S, Sasaki K, Ishikawa H, Sakurai H, Kuwano H. Minimally Invasive Salvage Operations for Esophageal Cancer after Definitive Chemoradiotherapy. Digestion, 2018 ; 97(1), 64-69.

  Kato H, Ono H, Hamamoto Y, Ishikawa H. Interaction between Medical Treatment and Minimally Invasive Surgical Treatment for the Malignancies of the Digestive Tract. Digestion, 2018 ; 97(1), 13-19.

  Takada K, Sato T, Kumada H, Koketsu J, Takei H, Sakurai H, Sakae T. Validation of the physical and RBE-weighted dose estimator based on PHITS coupled with a microdosimetric kinetic model for proton therapy. J Radiat Res, 2018 ; 59(1), 91-99.

  Nakata M, Hishiki T, Sakurai H, Saito T, Terui K, Mitsunaga T, Komatsu S, Ochiai H, Hino M, Ando K, Chikaraishi K, Aoki T, Okunushi T, Honma S, Fugo K, Yoshida H. Transurethral resection for botryoid bladder rhabdomyosarcoma. J Ped Surg Case Reports, 2018 ; 28, 37-40.

  Kurishima K, Miyazaki K, Watanabe H, Shiozawa T, Ishikawa H, Satoh H, Hizawa N. Lung cancer patients with synchronous colon cancer. Molecular and clinical oncology, 2018 ; 8(1), 137-140.

  Fukumitsu N, Okumura T, Takizawa D, Numajiri H, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Proton beam therapy for liver metastases from gastric cancer. J Radiat Res, 2017 ; 58(3), 357-362.

  石川仁, 三浦航星, 関野雄太, 石田俊樹, 馬場敬一郎, 森祐太郎, 田中圭一, 大西かよ子, 奥村敏之, 櫻井英幸. 前立腺癌の陽子線治療. 臨床放射線/金原出版, 2017 ; 62(11), 1601-1611.

  Kumada H, Naito F, Hasegawa K, Kobayashi H, Kurishima T, Takada K, Onishi T, Sakurai H, Matsumura A, Sakae T. Development of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba. Plasma and Fusion Research, 2017 ; 13, 2406006-2406006.

  Kasuya G, Ishikawa H, Tsuji H, Haruyama Y, Kobashi G, Ebner DK, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Makishima H, Nomiya T, Kamada T, Tsujii H, Working Group for Genitourinary T. Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy. Cancer Sci, 2017 ; 108(12), 2422-2429.

  Fukumitsu N, Terunuma T, Okumura T, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Comparison of rigid and deformable image registration accuracy of the liver during long-term transition after proton beam therapy. Imaging Med, 2017 ; 9(6), 149-154.

  Matsumoto Y, Hattori K, Arima H, Motoyama K, Azuma T, Ohnishi K, Fukumitsu N, Aihara T, Sakurai H. Folate-modified cyclodextrin improves the intratumoral accumulation of existing boron compounds. . Proceedings of YBNCT9, 2017 ; 80.

  Kumada H, Takada K, Onishi T, Naito F, Tanaka S, Matsumura A, Sakurai H, Aihara T, Matsumoto Y, Sakae T. Characteristic measurements for neutron beam of the linac-based neutron source for BNCT device in University of Tsukuba. Proceedings of YBNCT9, 2017 ; S2-1.

  Tamura M, Sakurai H, Mizumoto M, Kamizawa S, Murayama S, Yamashita H, Takao S, Suzuki R, Shirato H, Ito YM. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients. J Radiat Res, 2017; 58(3), 363-371.

  磯辺智範, 榮武二, 櫻井英幸. 筑波大学における放射線健康リスク科学教育システムの構築. FBNews, 2017 ; 490, 3-8.

  Makishima H, Ishikawa H, Tanaka K, Mori Y, Mizumoto M, Ohnishi K, Aihara T, Fukumitsu N, Okumura T, Sakurai H. A retrospective study of late adverse events in proton beam therapy for prostate cancer. Molecular and clinical oncology, 2017 ; 7(4), 547-552.

  Kumada H, Takeda K, Aihara T, Matsumura A, Sakurai H, Sakae T. Verification of dose estimation for Monte-Carlo based treatment planning system for boron neutron capture therapy. Physica Medica, 2017 ; 42(Sup.1), 25-26.

  Kumada H, Takada K, Aihara T, Matsumura A, Sakurai H, Sakae T. Application expansion of the Monte-Carlo based treatment planning system for BNCT to particle radiotherapy and X-ray therapy. Physica Medica, 2017 ; 42(Sup.1), 26.

  Furusawa Y, Yamanouchi Y, Iizumi T, Zhao Q, Mitsuhashi Y, Morita A, Enomoto A, Tabuchi Y, Kondo T. Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G2/M arrest and cell survival in cells with p53 defects under heat stress. Apoptosis : an international journal on programmed cell death, 2017 ; 22(10), 1225-1234.

  Fukushima H, Fukushima T, Suzuki R, Iwabuchi A, Hidaka K, Shinkai T, Masumoto K, Muroi A, Yamamoto T, Nakao T, Oshiro Y, Mizumoto M, Sakurai H, Sumazaki R. Comorbidity and quality of life in childhood cancer survivors treated with proton beam therapy. Pediatrics international : official journal of the Japan Pediatric Society, 2017 ; 59(10), 1039-1045.

  Moriya S, Tachibana H, Hotta K, Nakamura N, Sakae T, Akimoto T. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung. Med Phys, 2017 ; 44(9), 4474-4481.

  Fuse H, Komatsu K, Arakawa H, Sakae T, Fujisaki T. An infrared interactive patient position guidance and acquisition control system for use during radiotherapy treatment. Journal of radiotherapy in practice, 2017 ; 16(3), 303-310.

  Fukumitsu N, Okumura T, Numajiri H, Takizawa D, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Follow-up study of liver metastasis from breast cancer treated by proton beam therapy. Molecular and clinical oncology, 2017 ; 7(1), 56-60.

  Mizumoto M, Oshiro Y, Yamamoto T, Kohzuki H, Sakurai H. Proton Beam Therapy for Pediatric Brain Tumor. Neurol Med Chir (Tokyo), 2017 ; 57(7), 343-355.

  Terunuma T, Sakae T. Image Segmentation for Tumor Tracking by Deep Learning with Robustness for Obstacle Object Feature. MEDICAL PHYSICS, 2017 ; 44(6), 3175.

  Oshiro Y, Ohkohchi N. Three-Dimensional Liver Surgery Simulation: Computer-Assisted Surgical Planning with Three-Dimensional Simulation Software and Three-Dimensional Printing. Tissue Eng Part A, 2017 ; 23(11-12), 474-480.

  Moriya S, Tachibana H, Hotta K, Nakamura N, Sakae T, Akimoto T. Effectiveness of Dynamic Adaptive Proton Therapy with Computed Tomography Image Guidance in Abdomen. MEDICAL PHYSICS, 2017 ; 44(6), 2872.

  Feliciano CP, Tsuboi K, Suzuki K, Kimura H, Nagasaki Y. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice. Biomaterials, 2017 ; 129, 68-82.

  Masuda A, Matsumoto T, Takada K, Onishi T, Kotaki K, Sugimoto H, Kumada H, Harano H, Sakae T. Neutron spectral fluence measurements using a Bonner sphere spectrometer in the development of the iBNCT accelerator-based neutron source. Appl Radiat Isot, 2017 ; 127, 47-51.

  Fukumitsu N, Nitta K, Terunuma T, Okumura T, Numajiri H, Oshiro Y, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI. BMC Med Imaging, 2017 ; 17(1), 30-38.

  Miyazaki T, Ishikawa E, Matsuda M, Akutsu H, Osuka S, Sakamoto N, Takano S, Yamamoto T, Tsuboi K, Matsumura A. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome. J Neurooncol, 2017 ; 133(2), 277-285.

  Terunuma T, Tokui A, Sakae T. Markerless tumor tracking by classification of deep machine learning. Japanease Jounal of Medical Physics(医学物理), 2017; 37(Sup.1), 179.

  Takei H, Isobe T, Kitamura N, Sato T, Sakurai H, Sakae T. Characteristics of liquid ionization chamber for photon and electron beams. Japanease Jounal of Medical Physics(医学物理), 2017 ; 37(Sup.1), 161.

  榮武二. 学会誌電子化をどう活用するか. 医学物理, 2017 ; 37(4), 209.

  Sun L, Moritake T, Ito K, Matsumoto Y, Yasui H, Nakagawa H, Hirayama A, Inanami O, Tsuboi K. Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets. PLoS One, 2017 ; 12(4), e0176162.

  Moriya S, Tachibana H, Hotta K, Nakamura N, Sakae T. Comparison between current and advanced technique in image guidance for proton beam therapy in lung. Japanease Jounal of Medical Physics(医学物理), 2017 ; 37(Sup.1).

  Mizumoto M, Akutsu H, Yamamoto T, Fukushima T, Oshiro Y, Takizawa D, Tanaka K, Goto M, Okumura T, Matsumura A, Tsuboi K, Sakurai H. Preliminary Result of Hyperfractionated High-Dose Proton Beam Radiotherapy for Pediatric Skull Base Chordomas. J Cancer Ther, 2017 ; 8(4), 327-332.

  Kumada H, Mizuno Y, Hayashida T, Kurishima F, Nakamura K, Takada K, Sakurai H, Matsumura A, Sakae T. Development of a new production method for patient immobilization implement by combination with 3D Printing technique for BNCT. Japanease Journal of Medical Physics(医学物理）, 2017 ; 37(Sup.1), 125.

  
  
  

  ▼2016年度

  Oshiro Y, Mizumoto M, Okumura T, Fukuda K, Fukumitsu N, Abei M, Ishikawa H, Takizawa D, Sakurai H. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma. Radiother Oncol, 2017 ; 123(2), 240-245.

  Nambu I, Ozawa T, Sato T, Aihara T, Fujiwara Y, Otaka Y, Osu R, Izawa J, Wada Y. Transient increase in systemic interferences in the superficial layer and its influence on event-related motor tasks: a functional near-infrared spectroscopy study. J Biomed Opt, 2017 ; 22(3), 35008.

  Maruyama K, Tsuji H, Nomiya T, Katoh H, Ishikawa H, Kamada T, Wakatsuki M, Akakura K, Shimazaki J, Aoyama H, Tsujii H, Working Group for Genitourinary T. Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer. J Radiat Res, 2017 ; 58(2), 260-266.

  Fukuda K, Okumura T, Abei M, Fukumitsu N, Ishige K, Mizumoto M, Hasegawa N, Numajiri H, Ohnishi K, Ishikawa H, Tsuboi K, Sakurai H, Hyodo I. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. Cancer Sci, 2017 ; 108(3), 497-503.

  Takizawa D, Mizumoto M, Yamamoto T, Oshiro Y, Fukushima H, Fukushima T, Terunuma T, Okumura T, Tsuboi K, Sakurai H. A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors. Radiat Oncol, 2017 ; 12(1), 40.

  Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, Isobe T, Okamoto Y, Tanaka K, Shoda J. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. Scientific reports, 2017 ; 7, 43029.

  Demizu Y, Mizumoto M, Onoe T, Nakamura N, Kikuchi Y, Shibata T, Okimoto T, Sakurai H, Akimoto T, Ono K, Daimon T, Murayama S. Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan. Cancer Sci, 2017 ; 108(5), 972-977.

  Zenkoh J, Gerelchuluun A, Wang Y, Miwa Y, Ohno T, Tsuboi K. The abscopal effect induced by in situ-irradiated peripheral tumor cells in a murine GL261 brain tumor model. Transl Cancer Res, 2017 ; 6(1), 136-148.

  Takaoka EI, Miyazaki J, Ishikawa H, Kawai K, Kimura T, Ishitsuka R, Kojima T, Kanuma R, Takizawa D, Okumura T, Sakurai H, Nishiyama H. Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer. Jpn J Clin Oncol, 2017 ; 47(1), 67-73.

  Furusawa Y, Nakao-Aoki M, Matsumoto Y, Hirayama R, Kobayashi A, Konishi T. Equivalency of the quality of sublethal lesions after photons and high-linear energy transfer ion beams. J Radiat Res, 2017 ; 58, 803-808.

  Fukumitsu N, Okumura T, Sakurai H. Radiotherapy for liver cancer. J Gen Fam Med, 2017 ; 18(3), 126-130.

  Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H. Long-term follow-up after proton beam therapy for pediatric tumors: A Japanese national survey. Cancer Sci, 2017 ; 108, 444-447.

  菊池真維子, 中島政信, 室井大人, 高橋雅一, 百目木泰, 伊藤淳, 山口悟, 佐々木欣朗, 石川仁, 櫻井英幸, 加藤広行. 大動脈ステント内挿術施行後のsalvage食道癌手術の臨床経験. 日本気管食道科学会会報, 2016 ; 67(6), 423-428.

  Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis(dagger). Neurooncol Pract, 2016 ; 3(4), 272-280.

  Takada K, Kumada H, Liem PH, Sakurai H, Sakae T. Development of Monte Carlo based real-time treatment planning system with fast calculation algorithm for boron neutron capture therapy. Phys Med, 2016 ; 32, 1846-1851.

  櫻井英幸. 小児・AYA世代のがんの陽子線治療. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 137.

  福島紘子, 鈴木涼子, 穂坂翔, 八牧愉二, 小林千恵, 日高響子, 對馬依子, 新開統子, 増本幸二, 室井愛, 山本哲哉, 中尾朋平, 大城佳子, 水本斉志, 櫻井英幸, 福島敬, 須磨崎亮. QOL status after multimodal treatment with Proton Beam Therapy to the Head and Neck was as good as normal population. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 276.

  福島紘子, 鈴木涼子, 穂坂翔, 八牧愉二, 小林千恵, 新開統子, 増本幸二, 室井愛, 山本哲哉, 中尾朋平, 大城佳子, 水本斉志, 櫻井英幸, 福島敬, 須磨崎亮. Limited central nervous system damage after multimodal treatment with Proton Beam Therapy. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 277.

  日高響子, 福島紘子, 對馬依子, 穂坂翔, 鈴木涼子, 八牧愉二, 小林千恵, 清谷知賀子, 新開統子, 増本幸二, 室井愛, 山本哲哉, 中尾朋平, 水本斉志, 櫻井英幸, 福島敬, 須磨崎亮. Cognitive function of the childhood cancer survivor after the proton beam therapy. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 397.

  中尾朋平, 福島敬, 福島紘子, 鈴木涼子, 穂坂翔, 八牧愉二, 小林千恵, 新開統子, 増本幸二, 水本斉志, 須磨崎亮, 櫻井英幸. Proton beam therapy was utilized during intensive multidisciplinary approach for Ewing sarcoma without an increase of adverse events. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 276.

  大西かよ子, 奥村敏之, 石川仁, 中澤健介, 塩澤利博, 大城佳子, 関根郁夫, 佐藤幸夫, 檜澤伸之, 櫻井英幸. I期非小細胞肺癌高リスク症例に対する陽子線治療. 肺癌, 2016 ; 56(6), 784.

  石川由美香, 鈴木涼子, 水本斉志, 鮎澤香, 穂坂翔, 斎藤高, 中尾朋平, 福島敬, 櫻井英幸. 発達障害児に対する覚醒状態での陽子線治療に向けた介入. 日本小児血液・がん学会雑誌, 2016 ; 53(4), 440.

  奥脇一, 鈴木涼子, 福島敬, 穂坂翔, 福島紘子, 八牧愉二, 小林千恵, 中尾朋平, 増本幸二, 大城佳子, 水本斉志, 櫻井英幸, 須磨崎亮. Intensive multidisciplinary therapy with Proton Beam Therapy for rhabdomyosarcoma was conducted safely. 日本小児血液・がん学会雑誌, 2016 ; (4), 301.

  Harima Y, Ohguri T, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia, 2016 ; 32(7), 801-808.

  Kasuya G, Ishikawa H, Tsuji H, Nomiya T, Makishima H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Haruyama Y, Kobashi G, Tsujii H, Working Group for Genitourinary T. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy. Cancer, 2016 ; 122(20), 3225-3231.

  Ohnishi K, Okumura T, Ishikawa H, Oshiro Y, Mizumoto M, Numajiri H, Saito T, Fukumitsu N, Aihara T, Sakurai H. Proton Beam Therapy for High-risk Patients with Stage I Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys, 2016 ; 96(2S), E457-E458.

  Ishikawa H, Saito T, Iizumi T, Takizawa D, Ohnishi K, Mizumoto M, Kanuma R, Tanaka K, Numajiri H, Aihara T, Fukumitsu N, Okumura T, Sakurai H. Concurrent Chemo-Proton Therapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys, 2016 ; 96(2S), E192.

  Sakurai H, Ishikawa H, Okumura T. Proton beam therapy in Japan: current and future status. Jpn J Clin Oncol, 2016 ; 46(10), 885-892.

  Mizumoto M, Yamamoto T, Ishikawa E, Matsuda M, Takano S, Ishikawa H, Okumura T, Sakurai H, Matsumura A, Tsuboi K. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide. J Neurooncol, 2016 ; 130(1), 165-170.

  木幡拓海, 布施拓, 荒川寛貴, 小松賢司, 大川原佳紀, 安江憲治, 榮武二, 藤崎達也. 呼吸同期照射における呼吸信号取得位置による治療精度の検証. 日本放射線技術学会雑誌, 2016 ; 72(9), 870.

  福光延吉. モリブデン-99/テクネチウム-99m(99Mo/99mTc) 国産化と吸着剤の開発. 臨床核医学, 2016 ; 49(5), 74-77.

  富田哲也, 磯辺智範, 武居秀行, 小林大輔, 森祐太郎, 横田浩, 櫻井英幸, 榮武二. ヨード造影剤が陽子線治療計画における線量計算に及ぼす影響. 日本放射線技術学会雑誌, 2016 ; 72(9), 835.

  山田玲央, 山田和彦, 新里陽, 望月理玄, 日野原千速, 三宅大, 山澤邦宏, 橋本政典, 矢野秀朗, 小島康志, 猪狩亨, 石川仁. 陽子線治療後の食道癌対してサルベージ手術を行った一例. 日本臨床外科学会雑誌, 2016 ; 77(9), 2361.

  磯辺智範, 森祐太郎, 高田健太, 佐藤英介, 小林大輔, 富田哲也, 武居秀行, 梁川範幸, 榮武二. 医療における課題解決型教育プログラムの提案　診療放射線技師の教育を例に. 診療放射線学教育学, 2016 ; 4(1), 7-11.

  磯辺智範, 小林大輔, 富田哲也, 高橋英希, 森祐太郎, 武居秀行, 櫻井英幸, 榮武二. タイムアウトを応用したリスクマネージメント手法の構築. 日本放射線技術学会雑誌, 2016 ; 72(9), 817.

  Mori Y, Isobe T, Yamaguchi Y, Takei H, Kamizawa S, Terunuma T, Sato E, Takada K, Tadano K, Yoshimura Y, Sakurai H, Sakae T. Development of simple high-precision two-dimensional dose-distribution measurement method for proton beam therapy using imaging plate and EBT3. Australas Phys Eng Sci Med, Mori Y, Isobe T, Yamaguchi Y, Takei H, Kamizawa S, Terunuma T, Sato E, Takada K, Tadano K, Yoshimura Y, Sakurai H, Sakae T. Development of simple high-precision two-dimensional dose-distribution measurement method for proton beam therapy using imaging plate and EBT3. Australas Phys Eng Sci Med, 2016 ; 39(3), 687-696.

  HK L, Matsumoto Y, Furusawa Y, Kamada T. PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy. J Radiat Res, 2016 ; 57(5), 572-575.

  Murakami N, Kato S, Nakano T, Uno T, Yamanaka T, Sakurai H, Yoshimura R, Hiratsuka J, Kuroda Y, Yoshio K, Itami J. A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. BMC Cancer, 2016 ; 16, 640.

  Ishikawa M, Yamamoto T, Matsumura A, Hiratsuka J, Miyatake S, Kato I, Sakurai Y, Kumada H, Shrestha SJ, Ono K. Early clinical experience utilizing scintillator with optical fiber (SOF) detector in clinical boron neutron capture therapy: its issues and solutions. Radiat Oncol, 2016 ; 11(1), 105.

  Watanabe M, Tada M, Satomi T, Chikazu D, Mizumoto M, Sakurai H. Metastatic rectal adenocarcinoma in the mandibular gingiva: a case report. World J Surg Oncol, 2016 ; 14(1), 199.

  Takayanagi T, Nihongi H, Nishiuchi H, Tadokoro M, Ito Y, Nakashima C, Fujitaka S, Umezawa M, Matsuda K, Sakae T, Terunuma T. Dual ring multilayer ionization chamber and theory-based correction technique for scanning proton therapy. Med Phys, 2016 ; 43(7), 4150-4161.

  Mizumoto M, Oshiro Y. Preparation of pediatric patients for treatment with proton beam therapy. Deutschland, Germany: LAP LAMBERT Academic Publishing; 2016.

  Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan. Cancer Med, 2016 ; 5(7), 1519-1525.

  Hayashi Y, Mizumoto M, Akutsu H, Takano S, Matsumura A, Okumura T, Kawabe T, Zenkoh J, Sakurai H, Tsuboi K. Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal. Br J Radiol,2016 ; 89(1063), 20151051.

  Unoki T, Abiko Y, Toyama T, Uehara T, Tsuboi K, Nishida M, Kaji T, Kumagai Y. Methylmercury, an environmental electrophile capable of activation and disruption of the Akt/CREB/Bcl-2 signal transduction pathway in SH-SY5Y cells. Scientific reports, 2016 ; 6, 28944.

  Tamura M, Ito Y, Sakurai H, Mizumoto M, Kamizawa S, Murayama S, Yamashita H, Takao S, Suzuki R, Shirato H. SU-F-T-202: An Evaluation Method of Lifetime Attributable Risk for Comparing Between Proton Beam Therapy and Intensity Modulated X-Ray Therapy for Pediatric Cancer Patients by Averaging Four Dose-Response Models for Carcinoma Induction. Med Phys, 2016 ; 43(6), 3508.

  櫻井英幸. 小児腫瘍の陽子線治療. 小児の脳神経, 2016 ; 41(1), 52.

  山本哲哉, 水本斉志, 室井愛, 阿久津博義, 松田真秀, 石川栄一, 中井啓, 高野晋吾, 坪井康次, 櫻井英幸, 松村明. 小児脳腫瘍に対する陽子線治療の有用性. 小児の脳神経, 2016 ; 41(1), 82.

  五藤周, 増本幸二, 新開統子, 瓜田泰久, 高安肇, 田中秀明, 小林千恵, 福島敬, 須磨崎亮, 水本斉志, 櫻井英幸. 陽子線治療による放射線性腸炎予防のための腹腔鏡手術. 日本小児外科学会雑誌,2016 ; 52(3), 690.

  粟飯原輝人, 平塚純一, 石川仁, 大西かよ子, 福光延吉, 森田倫正, 神谷伸彦, 原田保, 櫻井英幸. 硼素中性子捕捉療法の18FBPA-PET検査と治療効果の検討. 頭頸部癌, 2016 ; 42(2), 208.

  Mizumoto M, Oshiro Y, Okumura T, Fukumitsu N, Numajiri H, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience. Int J Part Ther, 2016 ; 2(4), 570-578.

  
  
  

  ▼2015年度

  Ikeda M, Okusaka T, Mitsunaga S, Ueno H, Tamai T, Suzuki T, Hayato S, Kadowaki T, Okita K, Kumada H. Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res, 2016 ; 22(6), 1385-1394.

  Zenda S, Akimoto T, Mizumoto M, Hayashi R, Arahira S, Okumura T, Sakurai H. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses. Radiother Oncol, 2016 ; 118(2), 267-271.

  福光延吉, 黒﨑弘正, 中村順一, 中島利器, 徳田安則, 奥村敏之. 強度変調放射線治療で治療した流涎症の症例への99mTc04-唾液腺シンチグラフィの応用. 臨床核医学, 2016 ; 49(1), 2-4.

  Takada K, Isobe T, Sato E. Notes on the Ingenuity of the Monte Carlo Code PHITS. Igaku Butsuri, 2016 ; 35(4), 292-296.

  Tadano K, Isobe T, Sato E, Takei H, Kobayashi D, Mori Y, Tomita T, Sakae T. Basics of Monte-Carlo Simulation: Focusing on Dose-to-medium and Dose-to-water. Igaku Butsuri, 2016 ; 36(3), 148-150.

  Sato E, Isobe T, Yamamoto T, Matsumura A. Basic Principle and Image Analysis in the Diffusion Tensor Image. Igaku Butsuri, 2016 ; 36(2), 97-102.

  Sano K, Isobe T, Yang J, Win-Shwe TT, Yoshikane M, Nakayama SF, Kawashima T, Suzuki G, Hashimoto S, Nohara K, Tohyama C, Maekawa F. In utero and Lactational Exposure to Acetamiprid Induces Abnormalities in Socio-Sexual and Anxiety-Related Behaviors of Male Mice. Front Neurosci, 2016 ; 10, 228.

  Isobe T, Yamamoto T, Akutsu H, Sato E, Tadano K, Masumoto T, Sakae T, Matsumura A. Essentials of Brain MRS: Fundamentals and Clinical Applications. Igaku Butsuri, 2016 ; 36(2), 85-91.

  Isobe T, Okamoto Y, Hirano Y, Ando H, Takada K, Sato E, Shinoda K, Tadano K, Takei H, Kamizawa S, Mori Y, Suzuki H. Effect of biological factors on successful measurements with skeletal-muscle (1)H-MRS. Ther Clin Risk Manag, 12, 1133-1137.

  Isobe T, Mori Y, Takei H, Sato E, Tadano K, Kobayashi D, Tomita T, Sakae T. Handling Density Conversion in TPS. Igaku Butsuri, 2016 ; 36(3), 156-160.

  孫略, 人見剛, 二ツ矢浩一郎, 加藤守, 川内覚, 茂呂田孝一, 塚本篤子, 早川幹人, 榮武二, 松丸祐司, 千田浩一, 盛武敬. 多施設間IVR被ばく線量解析研究を支援するためのシステム構築. 日本放射線技術学会雑誌, 2015 ; 71(12), 1241-1247.

  松本孔貴. 難治性膵臓がんに対する中性子捕捉療法の効果解析. 日本膵臓病研究財団研究報告書 （第22回）, 2015 ; 41-53.

  Takada K, Kumada H, Isobe T, Terunuma T, Kamizawa S, Sakurai H, Sakae T, Matsumura A. Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy. Radiat Prot Dosimetry, 2015 ; 167(4), 584-590.

  Suzuki H, Hitomi S, Yaguchi Y, Tamai K, Ueda A, Kamata K, Tokuda Y, Koganemaru H, Kurihara Y, Ishikawa H, Yanagisawa H, Yanagihara K. Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. J Infect Chemother, 2015 ; 21(12), 849-856.

  Aihara T, Hiratsuka J, Ishikawa H, Kumada H, Ohnishi K, Kamitani N, Suzuki M, Sakurai H, Harada T. Fatal carotid blowout syndrome after BNCT for head and neck cancers. Appl Radiat Isot, 2015 ; 106, 202-206.

  Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Morita T, Kinoshita H. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015 ; 23(11), 3149-3156.

  Hirayama R, Uzawa A, Obara M, Takase N, Koda K, Ozaki M, Noguchi M, Matsumoto Y, Li H, Yamashita K, Koike S, Ando K, Shirai T, Matsufuji NF, Y. Determination of the relative biological effectiveness and oxygen enhancement ratio for micronuclei formation using high-LET radiation in solid tumor cells: And in vitro and in vivo study. Mutation Research, 2015 ; 793, 41-47.

  Fukumitsu N, Okumura T, Takizawa D, Makishima H, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Proton beam therapy for metastatic liver tumors. Radiother Oncol, 2015 ; 117(2), 322-327.

  Ishikawa H, Katoh H, Kaminuma T, Kawamura H, Ito K, Matsui H, Hirato J, Shimizu N, Takezawa Y, Tsuji H, Suzuki K, Ohno T, Nakano T, Group for Genitourinary Tumors at Gunma Heavy Ion Medical C. Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life. Anticancer Res, 2015 ; 35(10), 5559-5566.

  Kumada H, Takada K, Yamanashi K, Sakae T, Matsumura A, Sakurai H. Verification of nuclear data for the Tsukuba plan, a newly developed treatment planning system for boron neutron capture therapy. Appl Radiat Isot,2015 ; 106, 111-115.

  Takano S, Yamamoto T, Ishikawa E, Akutsu H, Nakai K, Matsuda M, Muroi A, Shibata Y, Mizumoto M, Tsuboi K, Matsumura A. Improvement of Long-term Results with Neoadjuvant Chemotherapy and Radiotherapy for Central Nervous System Germinoma. World neurosurgery, 2015 ; 84(3), 846-854.

  Mori Y, Isobe T, Takada K, Sato E, Kamizawa S, Takahashi H, Sakae T. Quantitative Assessment of 131I in Soil Originating from the Fukushima Daiichi Nuclear Power Plant Disaster using a Germanium Semiconductor Detector. Energy Procedia, 2015 ; 71, 370-376.

  Matsumoto Y, Hamada N, Aoki-Nakano M, Funayama T, Sakashita T, Wada S, Kakizaki T, Kobayashi Y, Furusawa Y. Dependence of the bystander effect for micronucleus formation on dose of heavy-ion radiation in normal human fibroblasts. Radiat Prot Dosimetry, 2015 ; 166(1-4), 152-156.

  Hong Z, Zenkoh J, Le B, Gerelchuluun A, Suzuki K, Moritake T, Washio M, Urakawa J, Tsuboi K. Generation of low-flux X-ray micro-planar beams and their biological effect on a murine subcutaneous tumor model. J Radiat Res, 2015 ; 56(5), 768-776.

  Fuse H, Shinoda K, Inohira M, Kawamura H, Miyamoto K, Sakae T, Fujisaki T. Note: Utilization of polymer gel as a bolus compensator and a dosimeter in the near-surface buildup region for breast-conserving therapy. The Review of scientific instruments, 2015 ; 86(9), 096103.

  Facoetti A, Vischioni B, Ciocca M, Ferrarini M, Furusawa Y, Mairani A, Matsumoto Y, Mirandola A, Molinelli S, Uzawa A, Vilches FG, Orecchia R. In vivo radiobiological assessment of the new clinical carbon ion beams at CNAO. Radiat Prot Dosimetry, 2015 ; 166(1-4), 379-382.

  Tamura T, Kurishima K, Nakazawa K, Ishikawa H, Satoh H, Hizawa N. Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer. Oncology letters, 2015 ; 10(2), 1135-1140.

  Mizumoto M, Oshiro Y, Takizawa D, Fukushima T, Fukushima H, Yamamoto T, Muroi A, Okumura T, Tsuboi K, Sakurai H. Proton beam therapy for pediatric ependymoma. Pediatrics international : official journal of the Japan Pediatric Society, 2015 ; 57(4), 567-571.

  Masunaga SI, Uzawa A, Hirayama R, Matsumoto Y, Sakurai Y, Tanaka H, Tano K, Sanada Y, Suzuki M, Maruhashi A, Ono K. The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With gamma-Rays or Reactor Neutron Beams. World J Oncol, 2015 ; 6(4), 398-409.

  Kamata K, Suzuki H, Kanemoto K, Tokuda Y, Shiotani S, Hirose Y, Suzuki M, Ishikawa H. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. J Infect Chemother,2015 ; 21(8), 596-603.

  Kumada H, Kurihara T, Yoshioka M, Kobayashi H, Matsumoto H, Sugano T, Sakurai H, Sakae T, Matsumura A. Development of beryllium-based neutron target system with three-layer structure for accelerator-based neutron source for boron neutron capture therapy. Appl Radiat Isot, 2015 ; 106, 78-83.

  Tamura T, Kurishima K, Watanabe H, Shiozawa T, Nakazawa K, Ishikawa H, Satoh H, Hizawa N. Characteristics of clinical N0 metastatic non-small cell lung cancer. Lung Cancer, 2015 ; 89(1), 71-75.

  Saito T, Ishikawa H, Ohnishi K, Aihara T, Mizumoto M, Fukumitsu N, Sugawara K, Okumura T, Sakurai H. Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review. Oncology letters, 2015 ; 10(1), 201-205.

  Murakami N, Okamoto H, Isohashi F, Murofushi K, Ohno T, Yoshida D, Saito M, Inaba K, Ito Y, Toita T, Itami J. A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan. J Radiat Res, 2015 ; 56(4), 735-741.

  Takano S, Akutsu H, Mizumoto M, Yamamoto T, Tsuboi K, Matsumura A. Neuroendoscopy Followed by Radiotherapy in Cystic Craniopharyngiomas-a Long-Term Follow-Up. World neurosurgery, 2015 ; 84(5), 1305-1315.

  Fukumitsu N, Numajiri H, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Terunuma T, Sakae T, Sakurai H. Prediction error and required internal margin provided for irregular respiratory movements: a phantom study. Jpn J Radiol, 2015 ; 33(6), 303-310.

  Uzawa A, Ando K, Kase Y, Hirayama R, Matsumoto Y, Matsufuji N, Koike S, Kobashi G. Designing a ridge filter based on a mouse foot skin reaction to spread out Bragg-peaks for carbon-ion radiotherapy. Radiother Oncol, 2015 ; 115(2), 279-283.

  Fukushima H, Fukushima T, Sakai A, Suzuki R, Kobayashi C, Oshiro Y, Mizumoto M, Hoshino N, Gotoh C, Urita Y, Komuro H, Kaneko M, Sekido N, Masumoto K, Sakurai H, Sumazaki R. Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2015 ; 20(3), 217-222.

  Ohkawa A, Mizumoto M, Ishikawa H, Abei M, Fukuda K, Hashimoto T, Sakae T, Tsuboi K, Okumura T, Sakurai H. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol, 2015 ; 30(5), 957-963.

• 2023年度
  
  
  

  2023年度

  1. 榮武二, 櫻井英幸, 磯辺智範, 佐藤英介, 森祐太郎. 放射線健康リスク科学基礎知識図解ノート: 金原出版; 2023. 184 p.

• 2023年度
  
  
  

  2023年度

  竹内春, 松本孔貴, 菅原裕, 東太志, 伊敷帆夏, 本山敬一, 櫻井英幸. フェニルボロン酸含有超分子を用いた新規ホウ素製剤の有効性評価. 第15回Quantum Medicine研究会; 2024.

  中井啓, 熊田博明, 松本孔貴, 水本斉志, 石川栄一, 橋本幸一, 櫻井英幸. 膠芽腫に対するBNCT 　―これまでの取り組みと進捗報告―. 東京コンベンションホール: 第37回高精度放射線外部照射部会学術大会; 2024.

  村上基弘, 石川仁, 飯泉天志, 水本斉志, 奥村敏之, 西山博之, 五所正彦, 櫻井英幸. 限局性前立腺癌に対する中等度寡分割陽子線治療：第2相試験の報告. 東京コンベンションホール: 第37回高精度放射線外部照射部会学術大会; 2024.

  Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Kanzaki H, Kobayashi K, Inoue M, Kiyono S, Nakamura M, Kanogawa N, Kondo T, Nakamoto S, Shiko Y, Ozawa Y, Inaba Y, Kurokawa T, Hanaoka H, Yamada S, Kato N. Phase Ib trial of durvalumab plus tremelimumab with particle therapy in HCC with macrovascular invasion: DEPARTURE trial. 名古屋国際会議場: 第21回日本臨床腫瘍学会学術集会; 2024.

  大谷篤史, 琴畑真貴子, 沼尻晴子, 富田哲也, 小林大輔, 鈴木慶史, 金子英恵, 櫻井英幸, 榮武二. 患者苦痛軽減を目指したボーラス加温の試み. 水戸三の丸ホテル　ステラ: 第20回茨城放射線腫瘍研究会; 2024.

  章競立, 斎藤高, 馬場敬一郎, 角谷泰輔, 村上基弘, 白瀧玄, 藤岡伝, 原田正比谷, 廣嶋悠一, 田中鈴子, 篠田和哉, 沼尻晴子, 玉木義雄, 奥村敏之, 櫻井英幸. 子宮頸癌根治治療例の中間評価MRIにおける腫瘍縮小率と予後の関係. 水戸三の丸ホテル　4Fステラ: 第20回茨城放射線腫瘍研究会; 2024.

  根本夕子, 丹下千鶴, 市村祥太, 五位渕優, 松田直也, 新津光, 飯泉天志, 斎藤高, 櫻井英幸. 自壊創を有する巨大な腋窩リンパ節腫瘍に対する放射線治療中の皮膚保護の経験. 水戸三の丸ホテル　ステラ: 第20回茨城放射線腫瘍研究会; 2024.

  原田正比谷, 斎藤高, 石田俊樹, 中村雅俊, 村上基弘, 馬場敬一郎, 飯泉天志, 牧島弘和, 沼尻晴子, 水本斉志, 中井啓, 櫻井英幸. 大腸癌術後仙骨前再発に続発した神経周囲進展に陽子線再照射を施行した症例. 水戸三の丸ホテル　4Fステラ: 第20回茨城放射線腫瘍研究会; 2024.

  牧島弘和, 飯泉天志, 斎藤高, 沼尻晴子, 中井啓, 水本斉志, 奥村敏之, 櫻井英幸. `Up to seven` を超える肝細胞癌に対する陽子線治療. 大阪市立総合医療センター　さくらホール: 第15回日本放射線外科学会; 2024.

  中村雅俊, 馬場敬一郎, 村上基弘, 石田俊樹, 飯泉天志, 斎藤高, 牧島弘和, 沼尻晴子, 水本斉志, 中井啓, 櫻井英幸. 切除不能気管原性腺様嚢胞癌に対し陽子線治療を行い長期生存が得られた2例. 大阪市立総合医療センター　さくらホール: 第15回日本放射線外科学会; 2024.

  水本斉志. セッション3　腫瘍2（体幹部腫瘍）. 大阪市立総合医療センター: 第15回日本放射線外科学会; 2024.

  後藤雅明, 野中哲生, 丸山大樹, 石井元樹, 香川賢司. サイバーナイフによるオリゴ転移に対する体幹部定位放射線治療のESTROコンセンサスに基づく遡及的研究. 大阪市立総合医療センター: 第15回日本放射線外科学会; 2024.

  Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Kanzaki H, Kobayashi K, Inoue M, Kiyono S, Nakamura M, Kanogawa N, Kondo T, Nakamoto S, Shiko Y, Ozawa Y, Inaba Y, Kurokawa T, Hanaoka H, Yamada S, Kato N. Phase Ib trial of durvalumab plus tremelimumab in combination with particle therapy in advanced hepatocellular carcinoma patients with macrovascular invasion: DEPARTURE trial. Foreign ed. San Francisco, CA & Online: ASCO Gastrointestinal Cancers Symposium 2024; 2024.

  竹内春, 松本孔貴, 菅原裕, 東太志, 伊敷帆夏, 本山敬一, 櫻井英幸. フェニルボロン酸含有超分子を用いた新規ホウ素製剤の有効性評価. 国内 ed. 特定国立研究開発法人理化学研究所　和光キャンパス　本部棟2階大会議室: 日本量子医科学会第3回学術大会; 2023.

  菅原裕, 松本孔貴, 竹内春, 櫻井英幸. 既存ホウ素製剤BPAの治療効果・細胞内集積性とアミノ酸トランスポータLAT1発現量と相関性の解析. 国内 ed. 特定国立研究開発法人理化学研究所　和光キャンパス　本部棟2階大会議室: 日本量子医科学会第3回学術大会; 2023.

  牧島弘和, 水本斉志, 中井啓, 沼尻晴子, 斎藤高, 大西洋, 櫻井英幸. 粒子線治療へのアクセス性に係る調査研究. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  福光延吉, 柴慎太郎, 渋谷圭, 小林大二郎, 宮坂勇平, 山口久志, 沼尻晴子, 若月優, 辻比呂志, 荻野浩幸, 打浪雄介, 加藤徳雄, 手良向聡, 中田美津子, 万代昌紀, 吉野孝之. 転移性肝腫瘍のシステマチックレビューと粒子線レジストリの解析. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  馬場敬一郎, 野中哲生, 丸山大樹, 石井元樹, 後藤雅明, 香川賢司. 再発性膠芽腫に対してサイバーナイフによる救済治療を行い生存期間の延長を得た3例. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  藤岡伝, 廣嶋悠一, 加沼玲子, 奥村敏之, 玉木義雄, 櫻井英幸. 前立腺癌術後生化学的再発に対する救済放射線療法の治療成績と安全性の検討. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  中村雅俊, 石田俊樹, 角谷泰輔, 村上基弘, 馬場敬一郎, 飯泉天志, 斎藤高, 沼尻晴子, 牧島弘和, 水本斉志, 中井啓, 櫻井英幸. 中枢型非小細胞肺癌cT1-4N0M0に対する中等度寡分割照射を用いた陽子線治療の成績. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  瀧澤大地, 伊藤周作, 白瀧玄, 馬場敬一郎, 飯泉天志, 鈴木清剛, 東直輝, 大西かよ子, 中井啓, 櫻井英幸. 頭皮の血管肉腫に対する同時化学放射線療法で完全奏功を得た父子の2例. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  大鹿理貴, 橘英伸, 守屋駿佑, 橘理絵, 山中将史, 松本和樹. X線CT用ゲル線量計を利用した陽子線治療装置のアイソセンタの三次元的な検証試験. パシフィコ横浜: 日本放射線腫瘍学会第36回学術大会; 2023.

  石田俊樹, 村上基弘, 馬場敬一郎, 中村雅俊, 飯泉天志, 斎藤高, 水本斉志, 沼尻晴子, 牧島弘和, 中井啓, 櫻井英幸. 食道癌に対するFOLFOX併用化学放射線療法の初期経験. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  水本斉志, 大城佳子, 角谷泰輔, 馬場敬一郎, 村上基弘, 石田俊樹, 中村雅俊, 飯泉天志, 斎藤高, 牧島弘和, 沼尻晴子, 中井啓, 櫻井英幸. 放射線治療中に感じる匂いに関する多施設共同前向き観察研究. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  新田葉月, 斎藤高, 松岡亮太, 中村雅俊, 馬場敬一郎, 村上基弘, 牧島弘和, 沼尻晴子, 水本斉志, 中井啓, 櫻井英幸. 鼻腔・副鼻腔原発神経内分泌癌に対して陽子線治療を施行した7例の報告. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  上間達也, 守屋駿佑, 榮武二, 伊藤康, 徳増健二, 吉岡靖生. 肺VMAT-SBRTにおける呼吸停止中の腫瘍位置変位が腫瘍投与線量に与える影響について. パシフィコ横浜: 日本放射線腫瘍学会第36回学術大会; 2023.

  小泉綾香, 佐藤幸代, 加藤雄一, 渡部大将, 若林亮, 猪平将也, 高橋瑞季, 菅原信二, 大城佳子. 前立腺癌IMRT患者の排泄日誌に基づく効果的な介入方法の検討. パシフィコ横浜: 日本放射線腫瘍学会第36回学術大会; 2023.

  守屋駿佑, 照沼利之, 富田哲也, 中村亮輔, 小松史明, 榮武二. 胸部ファントムを用いたEPIDによる腫瘍監視システムの開発. パシフィコ横浜: 日本放射線腫瘍学会第36回学術大会; 2023.

  若月優, 関口慶仁, 牧島弘和, 金子崇, 安田茂, 青木秀梨, 小此木範之, 村田和俊, 中嶋美緒, 石川仁, 山田滋. 炭素イオン線治療後の局所再発肝細胞癌に対する炭素イオン線再照射の治療成績. パシフィコ横浜: 日本放射線腫瘍学会第36回学術大会; 2023.

  斎藤高, 角谷泰輔, 馬場敬一郎, 藤岡伝, 白瀧玄, 新津光, 牧島弘和, 沼尻晴子, 水本斉志, 中井啓, 櫻井英幸. StageIII-IVA子宮頸癌における中間評価での腫瘍縮小率と予後の関係. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  後藤雅明, 野中哲生, 丸山大樹, 石井元樹, 中村雅俊, 馬場敬一郎, 香川賢司. 体幹部定位放射線治療を施行したオリゴ転移のESTROコンセンサスに基づく遡及的研究. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  後藤雅明, 二村保徳, 牧島弘和, 坂本規彰, 飯島達生, 玉木義雄, 櫻井鉄也, 奥村敏之, 櫻井英幸. 機械学習を用いた子宮頸がん病理組織像の放射線治療変化判定モデルの開発. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  兼安祐子, 中川富夫, 加藤真吾, 野田眞永, 青鹿友美, 櫻井英幸, 角谷泰輔, 土田圭祐, 有賀拓郎, 長尾彩加, 大野達也, 安藤謙, 村田和俊, 若月優, 小此木範之, 村上直也. 子宮体癌に対する根治的放射線治療の多施設共同研究調査と最適な線量評価法の検討. パシフィコ横浜 ノース: 日本放射線腫瘍学会第36回学術大会; 2023.

  Nakamura M. Particle beam therapy for non-small cell lung cancer. Chang Gung International Convention Center, Taoyuan, Taiwan. PTCOG-AO & ISTPT 2023. 2023.

  新津光, 福光延吉, 田中圭一, 水本斉志, 中井啓, 松田真秀, 石川栄一, 籏野健太郎, 橋本剛史, 櫻井英幸. 再発悪性神経膠腫に対するメチオニンPETを用いた治療計画の検討. グランフロント大阪: 第63回日本核医学学術総会; 2023.

  Matsumoto Y, Sugawara Y, Nakai K, Kumada H, Takeuchi H, Takada K, Sugimura T, Naito F, Sakurai H. Preclinical study to evaluate the in vitro biological effects of a novel linac-based boron neutron capture therapy system (iBNCT001). Korea: 2023 AACR-KCA Joint Conference 2023.

  Makishima H. Proton beam therapy for HCC exceeding“up-to-seven” criteria. Room17（311+312, 3F, Conference Center, Pacifico Yokohama）: ASO2023 the 3rd International Congress of the Asian Oncology Society; 2023.

  Ishida T. Long-term outcomes of proton beam therapy for elderly patients with prostate cancer. Room19（302, 3F, Conference Center, Pacifico Yokohama）: AOS 2023 the 3rd International Congress of the Asian Oncology Society; 2023.

  Hiroshima Y. Cost-effectiveness analysis of proton beam therapy for locally advanced unresectable pancreatic cancer. Room19（302, 3F, Conference Center, Pacifico Yokohama）: AOS2023 the 3rd International Congress of the Asian Oncology Society; 2023.

  Nakamura M, Ishida T, Sumiya T, Baba K, Murakami M, Iizumi T, Saito T, Numajiri H, Makishima H, Mizumoto M, Nakai K, Sakurai H. Outcomes after moderate hypofractionated proton beam therapy for centrally located node negative non-small cell lung cancer. Foreign ed. The-K Hotel, Seoul, Korea: FARO & KOSRO 2023; 2023.

  Iizumi T, Sawada T, Goto M, Li Y, Sumiya T, Ishida T, Hiroshima Y, Sekino Y, Saito T, Takizawa D, Makishima H, Numajiri H, Mizumoto M, Nakai K, Ishikawa H, Sakurai H. A case of malignant melanoma of external auditory canal treated with definitive proton beam therapy. Foreign ed. The-K Hotel, Seoul, Korea: FARO & KOSRO 2023; 2023.

  Niitsu H, Makishima H, Iizumi T, Saitoh T, Numajiri H, Nakai K, Mizumoto M, Okumura T, Sakurai H. Outcome of proton beam therapy for primary hepatocellular carcinoma with “unfavorable” macroscopic classification. Foreign ed. San Diego Convention Center: 2023 ASTRO Annual meeting; 2023.

  Goto M, Futamura Y, Makishima H, Sakamoto N, Iijima T, Tamaki Y, Sakurai T, Sakurai H. Development of a machine learning model to evaluate changes during radiotherapy in cervical cancer tumor cells. Foreign ed. San Diego Convention Center: 2023 ASTRO Annual meeting; 2023.

  Wakatsuki M, Makishima H, Mori Y, Kaneko T, Yasuda S, Okada N, Nakajima M, Murata K, Okonogi N, Aoki S, Ishikawa H, Yamada S. Clinical Outcomes of Carbon-Ion Radiotherapy for Large-Sized (≥4cm) Hepatocellular Carcinoma. Foreign ed. Arlington: 2023 ASTRO Annual Meeting; 2023.

  Mori Y, Wakatsuki M, Makishima H, Takashi K, Ishikawa H, Yasuda S, Okada N, Nakajima M, Murata K, Aoki S, Yamada S. Long-Term Clinical Outcome of Carbon Ion Radio Therapy for Hepatocellular Carcinoma in the Caudate Lobe. Foreign ed. Arlington: 2023 ASTRO Annual Meeting; 2023.

  瀧澤大地, 大西かよ子, 白瀧玄, 馬場敬一郎, 中井啓, 鈴木貴明, 櫻井英幸. 原発性涙嚢腺癌に対し、放射線単独根治照射にて長期制御を認めた1例. 徳島県郷土文化会館: 第59回日本医学放射線学会秋季臨床大会; 2023.

  松本孔貴, 菅原裕, 竹内春, 李宜諾, 櫻井英幸. 放射線抵抗性腫瘍に対してmodulated electro-hyperthermia(mEHT) は効率的な治療効果を誘導する 国内 ed. 伊勢原市民文化会館: 日本ハイパーサーミア学会第40回大会; 2023.

  飯泉天志, 奥村敏之, 角谷泰輔, 村上基弘, 石田俊樹, 中村雅俊, 関野雄太, 斎藤高, 瀧澤大地, 沼尻晴子, 牧島弘和, 水本斉志, 中井啓, 櫻井英幸. 単発5㎝超の肝細胞癌に対する陽子線治療. 国内 ed. 大阪国際会議場: 第59回日本肝癌研究会; 2023.

  森康晶, 若月優, 牧島弘和, 廣嶋悠一, 金子崇, 青木秀梨, 小此木範之, 中嶋美緒, 村田和俊, 石川仁, 辻比呂志, 山田滋. 尾状葉の肝細胞癌に対する重粒子線治療の臨床成績. 国内 ed. 大阪国際会議場: 第59回日本肝癌研究会; 2023.

  新津光, 牧島弘和, 飯泉天志, 斎藤高, 沼尻晴子, 中井啓, 水本斉志, 奥村敏之, 櫻井英幸. TACE不適な初発肝細胞癌に対する陽子線治療. 国内 ed. 大阪国際会議場: 第59回日本肝癌研究会; 2023.

  Moriya S, Terunuma T, Takahashi K, Kanda N, Sakae T. Evaluation of Deep Learning-Based Markerless Tumor Tracking of Irregular Respiratory Amplitude Using a Dynamic Lung Phantom. United States: AAPM 65th Annual Meeting & Exhibition; 2023.

  Komatsu F, Terunuma T, Sakae T. Deep learning-based lung tumor segmentation on beam’s-eye view via orthogonal x-ray images: A concept study. Houston, Texas: AAPM 65th Annual Meeting & Exhibition; 2023.

  白川真, 河本紗季, Zaboronok A, 熊田博明, 榮武二, 松村明, 亀川展幸, 竹内亮太, 堀均, 鈴木実. 新規BNCT用薬剤としてイオン液体の評価. 国内 ed. 横浜シンポジア　横浜商工会議所　第19回日本中性子捕捉療法学会学術大会; 2023.

  中井啓, 鶴淵隆夫, 石川栄一, 水本斉志, 竹村匡恵, 橋本幸一, 林利允, 松本孔貴, 熊田博明, 櫻井英幸. BNCT社会実装の動向および初発膠芽腫にたいするBNCT医師主導治験進捗報告. 国内 ed. 横浜シンポジア　横浜商工会議所　第19回日本中性子捕捉療法学会学術大会; 2023.

  大谷内将至, 髙田真志, 八木茄津未, 熊田博明, 田中進. iBNCT中性子源のリアルタイムモニタリングの開発. 国内 ed. 横浜シンポジア　横浜商工会議所　第19回日本中性子捕捉療法学会学術大会; 2023.

  熊田博明, 井垣浩, 田中浩基, 中村哲志, 増田明彦, 松本孔貴. BNCT装置と中性子ビームの国際標準化にむけて. 国内 ed. 横浜シンポジア　横浜商工会議所　第19回日本中性子捕捉療法学会学術大会; 2023.

  井垣浩, 鈴木実, 中村哲志, 熊田博明. 中性子ビーム特性評価ガイドライン（仮名）の現状と展望. 国内 ed. 横浜シンポジア　横浜商工会議所　第19回日本中性子捕捉療法学会学術大会; 2023.

  牧島弘和, 飯泉天志, 長谷川直之, 櫻井英幸. ”Up to seven" を超える肝細胞癌に対する陽子線治療. 国内 ed. 奈良県コンベンションセンター，JWマリオット・ホテル奈良（奈良県奈良市）: 第59回　日本肝臓学会総会; 2023.

  若月優, 牧島弘和, 金子崇. 4㎝以上肝細胞癌に対する重粒子線治療成績：保険適用となった重粒子線治療の有用性と今後の課題. 国内 ed. 奈良県コンベンションセンター，JWマリオット・ホテル奈良（奈良県奈良市）: 第59回　日本肝臓学会総会; 2023.

  Oshiro Y, Mizumoto M, Sumiya T, Iizumi T, Numajiri H, Nakai K, Sakurai H. Research on light flash during proton beam therapy and photon radiotherapy. Multicenter prospective study. Foreign ed. Madrid, Spain: 61st Annual PTCOG Conference; 2023.

  Nakai K, Mizumoto M, Takada K, Kumada H, Matsumoto Y, Hayashi T, Ishikawa E, Matsumura A, Hashimoto K, Sakuai H. Simulation of normal Brain dosimetry of bnct with fractionated x-Ray therapy for application to newly diagnosed glioblastoma. Foreign ed. Madrid, Spain: 61st Annual PTCOG Conference; 2023.

  Mizumoto M, Li Y, Oshiro Y, Nitta H, Saito T, Iizumi T, Makishima H, Numajiri H, Maruo K, Sakurai H. A Retrospective Study of Renal Growth after Proton Beam Therapy for Pediatric Malignant Tumor Foreign ed. Madrid, Spain: 61st Annual PTCOG Conference; 2023.

  Kumada H, Li Y, Takada K, Tanaka S, Sugimura T, Sato M, Matsumura A, Sakae T, Sakurai H. Development of the extended collimator for accelerator-based boron neutron capture therapy. Foreign ed. Madrid, Spain: 61st Annual PTCOG Conference; 2023.

  Komatsu F, Terunuma T, Moriya S, Sakae T. Evaluation of noise robustness in patient-specific deep learning using orthogonal X-ray fluoroscopic images for markerless tumor tracking. Foreign ed. Madid, Spain: 61st Annual PTCOG Conference; 2023.

  Hiroshima Y, Kondo M, Sawada T, Hoshi S, Okubo R, Iizumi T, Numajiri H, Okumura T, Sakurai H. Cost-effectiveness of proton beam therapy versus conventional radiation therapy for unresectable pancreatic cancer. Foreign ed. Madrid, Spain: 61st Annual PTCOG Conference; 2023.

  角谷泰輔, 斎藤高, 沼尻晴子, 石田俊樹, 中村雅俊, 飯泉天志, 牧島弘和, 中井啓, 水本斉志, 櫻井英幸. 初発膣癌に対する小線源治療の成績. 国内 ed. 神戸国際会議場　４F　401+402会議室: 公益社団法人日本放射線腫瘍学会　小線源治療部会　第25回学術大会; 2023.

  藤岡伝, 斎藤高, 角谷泰輔, 飯泉天志, 牧島弘和, 沼尻晴子, 水本斉志, 中井啓, 櫻井英幸. 子宮頸癌・子宮体癌局所再発に対する組織内照射の初回治療法別の成績. 国内 ed. 神戸国際会議場　4F　401+402: 公益社団法人日本放射線腫瘍学会　小線源治療部会　第25回学術大会; 2023.

  Iizumi T, Sawada T, Goto M, Li Y, Sumiya T, Ishida T, Hiroshima Y, Nakamura M, Sekino Y, Saito T, Takizawa D, Numajiri H, Mizumoto M, Nakai K, Ishikawa H, Sakurai H. Long-term outcomes of proton beam therapy for elderly patients with prostate cancer. Foreign ed. Messe Wien Exhibition Congress Center, Vienna, Austria: ESTRO 2023; 2023.

  Hiroshima Y, Kondo M, Sawada T, Hoshi S, Okubo R, Iizumi T, Numajiri H, Okumura T, Sakurai H. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer. Foreign ed. Messe Wien Exhibition Congress Center, Vienna, Austria: ESTRO 2023; 2023.

  新津光, 福光延吉, 田中圭一, 水本斉志, 中井啓, 松田真秀, 石川栄一, 籏野健太郎, 橋本剛史, 櫻井英幸. 悪性神経膠腫に対するメチオニンPETを用いた治療計画の検討. パシフィコ横浜: 第82回日本医学放射線学会総会; 2023.